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Abstract
Although the under-ﬁve mortality rate in Malawi has been declining since 1960, it still
remains one of the highest in the world. In order to appropriately target interventions to
achieve substantial reductions in deaths among children under the age of ﬁve years in Malawi,
there is an ongoing need for better knowledge of the proportion of cause-speciﬁc under-ﬁve
mortality in the country. Responding to this need, this study has estimated the proportion
of under-ﬁve mortality directly attributable to HIV/AIDS in Malawi during the period 2000
to 2004. The study used some of the existing indirect methods and mathematical models. To
a larger extent, the study adopted the methods and approaches recommended by UNAIDS
and WHO, particularly those implemented in DemProj and AIDS Impact Model both of
which are part of the Spectrum package. HIV/AIDS is estimated to have directly caused
about 12.6 percent of under-ﬁve mortality in Malawi between 2000 and 2004 and to have
signiﬁcantly hampered achievement of the country's overall under-ﬁve mortality reduction
goals. Although expansion of coverage of treatment with Nevirapine (which is the currently
available prevention of mother-to-child transmission (PMTCT) service in Malawi) would
help reduce HIV/AIDS attributable under-ﬁve mortality, the conclusion drawn from the
ﬁndings of this study is that in order to make substantial contributions to the country's
overall under-ﬁve mortality reduction goals, Malawi needs to intensify its eﬀorts in all the
four key components of a comprehensive set of PMTCT services. Furthermore, Malawi
also needs to strengthen its eﬀorts in addressing other major causes of under-ﬁve mortality
besides putting in place a comprehensive set of PMTCT services in order to achieve further
substantial reductions in deaths among children less than ﬁve years of age.
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Chapter 1
Introduction
1.1 Background to the study
Most countries in the world registered substantial reductions in mortality among infants and
children during the late 20th century (Ahmad et al., 2000). However, under-ﬁve mortality
still remains one of the leading challenges for public health especially in the developing world.
About 11 million children still die every year before their ﬁfth birthday worldwide and more
than 10 million of these deaths occur in the developing world (Hill and Amouzou, 2006; Black
et al., 2003). Within the developing world, Sub-Saharan Africa (SSA) is the most severely
aﬀected region and accounts for more than one-third of global under-ﬁve deaths (Hill and
Amouzou, 2006).
Factors responsible for the high levels of under-ﬁve mortality in the developing world and
SSA in particular are many and varied. The high mortality levels are either the eﬀect of
poor social, economic, cultural, and health system conditions that operate through a set
of proximate determinants that directly inﬂuence the risk of disease and the outcome of
disease processes proposed by Mosley and Chen (1984) or negative changes in the proximate
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determinants themselves. A study conducted by Rutstein (2000) illustrates the association
between high mortality among children less than ﬁve years of age and negative changes in
some of the proximate determinants of child mortality in developing countries. Factors
examined by Rutstein (2000) include fertility behaviours, nutritional status of children
and patterns of breastfeeding and infant feeding, maternal and child health status and
the use of health services, environmental health conditions and socioeconomic factors.
Although these factors inﬂuence the occurrence of a wide spectrum of childhood diseases,
only ﬁve communicable diseases (pneumonia, diarrhea, malaria, measles and HIV/AIDS)
are responsible for more than half of deaths in children under the age of ﬁve years in
developing countries (Bryce et al, 2005; WHO, 2005a). Being the world's most severely
HIV/AIDS aﬀected region (UNAIDS 2006), the under-ﬁve mortality burden of HIV/AIDS
is most pronounced in SSA. There is an indication that paediatric HIV infection contracted
through mother-to-child transmission (MTCT) is signiﬁcantly contributing to the observed
level of under-ﬁve mortality in SSA countries with high adult HIV prevalence (Adetunji,
2000; Walker, 2002; Garenne and Gakusi, 2006).
Although the under-ﬁve mortality rate (U5MR) in Malawi has been declining since 1960 (Hill
et al, 1998; Ahmad et al., 2000, UNICEF, 1998 and 2005), Malawi's under-ﬁve mortality
remains one of the highest in the world. As of 2004, Malawi's under-ﬁve mortality was ranked
19 in the world in terms of severity (UNICEF, 2005). With respect to adult HIV/AIDS
infection, Malawi also has one of the highest prevalence rates in the world. According to
UNAIDS (2006), HIV prevalence rate among adults aged 15 to 49 stands at 14.1%. Without
doubt, the high adult HIV prevalence in Malawi has an eﬀect on the levels of under-ﬁve
mortality in the country. However, the magnitude of the contribution of HIV/AIDS to the
most recent estimates of under-ﬁve mortality in Malawi is not clearly known. In order to
appropriately target interventions to reduce deaths among children under the age of ﬁve years
and to monitor progress there remains an ongoing need to understand better the proportion
of cause-speciﬁc under-ﬁve mortality. Therefore, this study aims at estimating the direct
contribution of HIV/AIDS to the observed level of under-ﬁve mortality in Malawi during the
period 2000 to 2004.
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1.2 Statement of the problem
The most recent estimates of U5MR in Malawi available at the time of conducting this
study are based on the 2004 Malawi Demographic and Health Survey (DHS). The estimates
indicate that the number of deaths among children aged below ﬁve years stood at 133 deaths
per 1 000 live births for the period 2000 to 2004 (NSO and ORC Macro, 2005). However, the
proportion of under-ﬁve mortality that can be directly attributed to HIV/AIDS contracted
through MTCT during this period is not clearly known. Therefore, there is need for estimates
of the under-ﬁve mortality directly attributable to HIV/AIDS during this period to assess
the magnitude by which prevention of mother-to-child transmission (PMTCT) programmes
currently being implemented in Malawi would potentially have reduced this observed level
of under-ﬁve mortality.
1.3 Aim and objectives of the study
The aim of this study is to estimate the direct contribution of HIV/AIDS to the observed
level of under-ﬁve mortality in Malawi during the period 2000 to 2004. Although there are
many ways in which adult HIV/AIDS could aﬀect the level of under-ﬁve mortality as outlined
by Adetunji (2000) and Walker et al. (2002), this study will only estimate the contribution
of HIV/AIDS to under-ﬁve mortality that resulted through vertical or perinatal transmission
of HIV from infected mothers to their children. Thus, estimates of the indirect eﬀects of
adult HIV/AIDS on under-ﬁve mortality are outside the scope of this study. Speciﬁcally,
the objective of this study is to estimate how much of the under-ﬁve mortality observed in
Malawi for the period 2000 to 2004 is directly attributable to HIV/AIDS.
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1.4 Research question
This study attempts to answer the following question: What proportion of the under-ﬁve
mortality observed in Malawi for the period 2000 to 2004 would be directly attributed to
HIV/AIDS?
1.5 Rationale and signiﬁcance of this study
Like majority of countries in the world, Malawi signed the Millennium Declaration that
was adopted in September 2000 (http://www.ohchr.org/english/law/millennium.htm) and
therefore became party to the Millennium Development Goal (MDG) of reducing by two
thirds the U5MR observed in 1990 by 2015 (http://www.un.org/millenniumgoals/; Hill and
Amouzou, 2006; Walker et al., 2002, Malawi millennium development goals report 2003).
This reduction translates into an annual average reduction rate of 4.3%.
Malawi's U5MR was one of the highest in SSA in 1990. Estimates based on the 1992 Malawi
DHS indicate that the number of deaths among children aged below ﬁve years for the period
1988 to 1992 was 234 deaths per 1 000 live births (NSO and ORC Macro, 1994). This means
that Malawi targets to reduce its U5MR to 78 deaths per 1 000 live births by the year 2015,
which is still high by world standards.
Although Malawi experienced a decline in under-ﬁve mortality from 234 deaths per 1 000
live births in 1990 to 133 deaths per 1 000 live births in 2004 (NSO and ORC Macro, 1994
and 2005), the annual average rate of reduction (3.96%) during this period is lower than
the expected target of 4.3%. Thus, Malawi is slightly oﬀ track in meeting the child-survival
MDG. Therefore, in order to properly target interventions to achieve further substantial
reductions in U5MR, the Malawian government and other stakeholders need cause-speciﬁc
estimates of the country's under-ﬁve mortality. Malawi being a country with one of the
highest HIV prevalence rates in the world, it is of interest to estimate the proportion of under-
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ﬁve mortality that is directly attributable to HIV/AIDS to guage the potential contribution
of PMTCT programmes towards meeting the overall child-survival MDG. Further, for the
ﬁrst time Malawi now has national HIV prevalence estimates for men and women derived
from the 2004 Malawi DHS which included HIV testing (NSO and ORC Macro, 2005). As
estimates of HIV prevalence are an integral part of the process of estimating the direct eﬀect
of HIV/AIDS on under-ﬁve mortality, it is inevitable to incorporate the information on HIV
prevalence from this general population-based survey into the existing data and make new
estimates of the direct impact of HIV/AIDS on under-ﬁve mortality in Malawi. Results of
this study are expected to be of policy relevance to Malawi and other countries experiencing
similar HIV prevalence and mortality patterns.
1.6 Conceptual framework
This study is based on the premise that the number of children under the age of ﬁve years who
die of HIV/AIDS is directly related to the number of children who acquired HIV infection
from their mothers. Therefore, the proportion of under-ﬁve year old children dying from
HIV/AIDS is a function of the proportion of HIV-infected mothers, the rate of MTCT and
the proportion of infected children who die before their ﬁfth birthday (Adetunji, 2000).
1.7 Research methodology
While population-based data on total under-ﬁve mortality are increasingly available
through the DHS (http://www.measuredhs.com/), population-based epidemiological data
are extremely limited in SSA countries. In most countries reliable data on cause of death are
uncommon because vital registration systems have extremely limited coverage (Adetunji,
2000; Salomon and Murray, 2001; Walker et al. 2002). For this reason, demographers
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and health researchers have tended to resort to indirect methods, including the use of
mathematical models in estimating the proportion of cause-speciﬁc under-ﬁve mortality.
With respect to HIV/AIDS, some of the indirect methods and mathematical models used
to estimate its contribution towards under-ﬁve mortality include those reported by Adetunji
(2000), Walker et al. (2002), Zaba et al. (2003), Stover (2005) and Johnson and Dorrington
(2006). This study uses some of the existing indirect methods and mathematical models
to derive estimates of under-ﬁve mortality directly attributable to HIV/AIDS in Malawi
for the period 2000 to 2004. To a larger extent, the study adopted the methods and
approaches recommended by UNAIDS and WHO that are implemented in DemProj and
AIDS Impact Model computer packages (The UNAIDS Reference Group on Estimates,
Models and Projections, 2003; Stover and Kirmeyer, 2004; Stover 2005). No new data
were collected, instead the study used secondary data and published reports.
1.8 Deﬁnitions of key concepts
The following deﬁnitions of the key concepts or terms are used in this study.
Acquired Immunodeﬁciency Syndrome (AIDS): A disease of the body's immune
system caused by the human immunodeﬁciency virus (HIV). It is characterized by the death
of CD4 cells (an important part of the body's immune system), which leaves the body
vulnerable to life-threatening conditions such as infections and cancers.
Death: Permanent disappearance of all evidence of life at any time after birth has taken
place.
Epidemic: A disease that has spread rapidly through a segment of the human population
in a given geographic area.
Human Immunodeﬁciency Virus (HIV): The virus that causes AIDS. HIV belongs
to the retrovirus family, and has two subtypes: HIV-1, which is responsible for most HIV
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infections throughout the world, and HIV-2 which is found primarily in West Africa.
HIV prevalence: The number of HIV-infected people in a population at a given time.
Mortality: A general term for incidence of deaths in a population or group.
Mother-to-Child Transmission (MTCT): The passage of HIV from an HIV-infected
mother to her infant. The infant may become infected while in the mother's womb, during
labour and delivery, or through breastfeeding.
Sub-Saharan Africa: The term used to describe the area of the African continent which
lies south of the Sahara desert.
Under-ﬁve mortality: The probability of dying between birth and the ﬁfth birthday.
Women of reproductive age: Women aged from 15 to 49 years.
1.9 Structure of the thesis
This chapter has outlined the main research problem under investigation in this study. The
chapter has presented the main aims and objectives of this study and provided the rationale
for carrying out the study. This chapter has also brieﬂy described the conceptual framework
for this study as well as the methodology used. Chapter two presents a review of the
literature on a number of aspects pertaining to this study, which include: a brief history of
HIV/AIDS; an overview of the global HIV/AIDS situation; an overview of the HIV/AIDS
situation in Malawi; mechanisms through which HIV/AIDS contributes to child mortality;
and ways of reducing HIV/AIDS attributable mortality in children. Chapter three provides
a detailed description of the methods and approaches used in this study. Chapter four
contains the results of the study. Chapter ﬁve presents a discussion of the results of the
study and conclusions drawn from the ﬁndings. Lastly, the Appendix contains selected
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programs written in R that were used to obtain the results of this study.
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Chapter 2
Literature review
This chapter presents a review of the literature on a number of aspects pertaining to this
study. The chapter consists of six sections. The ﬁrst section presents a brief natural history of
HIV/AIDS. The second section presents an overview of the global HIV/AIDS situation. The
third section presents an overview of the HIV/AIDS situation in Malawi. The fourth section
describes the mechanisms through which HIV/AIDS contributes to child mortality. The ﬁfth
section presents ways of reducing HIV/AIDS attributable mortality in children. Finally,
the sixth section presents information pertaining to Malawi's response to the HIV/AIDS
epidemic and eﬀorts to to reduce under-ﬁve mortality attributable to HIV/AIDS.
2.1 Brief natural history of HIV/AIDS
AIDS initially emerged as two rare illnesses that aﬀected a few homosexual men in California
and New York City in the United States of America in 1981. These were ﬁve cases of
Pneumocystis carinii pneumonia (CDC, 1981a) and 26 cases of a vascular skin tumor known
as Kaposi's sarcoma among young and otherwise health homosexual men (CDC, 1981b).
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It was discovered that both of these rare diseases were associated with a deﬁciency in the
immune system evidenced by a decline in the number of helper T lymphocytes (CD4 + T
Lymphocytes) (Brookmeyer and Gail, 1994:3). However, case reports of all these patients
indicated that none of them suﬀered from any underlying illness that would be responsible
for the development of these often fatal and uncommon diseases (CDC, 1981a; CDC, 1981b;
Brookmeyer and Gail, 1994:3; Kelly and St. Lawrence, 1988:2). The Centers for Disease
Control and Prevention (CDC) then named the syndrome accounting for these few cases of
mysterious illnesses as acquired immune deﬁciency syndrome (AIDS) in 1982 (Brookmeyer
and Gail, 1994:3).
The CDC deﬁned AIDS as a disease that was "at least moderately predictive of a defect
in cell-mediated immunity, occurring in a person with no known cause for diminished
resistance to that disease" such as Pneumocystis carinii pneumonia, Kaposi's sarcoma
and serious opportunistic infections (CDC, 1982). From June 1, 1981 to September 15,
1982, the CDC received reports of 593 AIDS cases out of which 243 (41%) cases had died
(CDC, 1982). Thereafter, the number of AIDS cases and deaths began to rise, but the
underlying causes of the immune deﬁciencies seen in the AIDS cases were unknown. In
response, medical investigators scrambled to ﬁnd a cause and more importantly a cure for
this new disease. Then in 1983, investigators at the Institut Pasteur in France identiﬁed
unusual serum antibodies in a majority of AIDS patients and isolated a retrovirus that they
believe to be responsible for those antibodies (Cichocki, 2006). They named this virus as
lymphadenopathy-associated virus (LAV) (Kelly and St. Lawrence, 1988:2). A year later the
United States government announced that their scientist, Dr. Robert Gallo of the National
Cancer Institute isolated a retrovirus called human T-cell lymphotropic virus type III (HTLV-
III), that he too claimed was responsible for the AIDS outbreak. This resulted in a dispute
between teams from the two research institutions (Barnett and Blaikie, 1992:2). Two years
later it was conﬁrmed that HTLV-III and LAV were actually the same virus (Cichocki 2006;
Kelly and St. Lawrence, 1988:2), and Gallo was still credited with its discovery (Cichocki,
2006). Following this conﬁrmation, an international committee of scientists renamed the
virus as Human Immunodeﬁciency Virus (HIV) (Cichocki, 2006; Kelly and St. Lawrence,
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1988:2; Brookmeyer and Gail, 1994:4).
The discovery of HIV set the stage for advancing knowledge about the dynamical features
of HIV and AIDS. A wealth of information is now available on the transmission mechanism
of HIV and the progression from HIV infection through AIDS. It is now known that HIV
transmission can occur when there is contact between speciﬁc body ﬂuids, particularly blood,
vaginal secretions, semen, pre-ejaculatory ﬂuid and breast milk of an HIV-infected person and
the blood and/or mucous membranes of an uninfected person (Lewthwaite andWilkins, 2005;
Schoeberlein, 2001; Levy, 1993). Currently there is no evidence that HIV can be transmitted
through pure tears, mucous from the nose, saliva, sweat, urine and feces (Schoeberlein, 2001;
Levy, 1993).
It is also now known that in adults, after acquisition of HIV, there are at least three phases
to the course of HIV infection, which include primary HIV infection phase, latent phase,
and symptomatic HIV infection phase (San Francisco AIDS Foundation 2006; Lewthwaite
and Wilkins, 2005; Mindel and Tenant-Flowers, 2001; Bannister et al., 2000). Primary HIV
infection, which is also called acute HIV infection or seroconversion illness represents the ﬁrst
stage of HIV infection after the acquisition of HIV when antibodies are developing (Mindel
and Tenant-Flowers, 2001). During the primary or acute HIV infection phase, HIV makes
its way to the lymph nodes and actively replicates and releases new virus particles into the
bloodstream (San Francisco AIDS Foundation 2006). People at this stage often have a very
high HIV viral load and the concentration of CD4+ T cells measured in their blood declines
(Mindel and Tenant-Flowers, 2001; Bannister et al, 2000; Perelson and Nelson, 1999; Levy,
1993). Also during the primary or acute HIV infection phase some people experience ﬂu-
like symptoms, such as fevers, chills, night sweats, and rashes which usually last between
two to six weeks and resolve without speciﬁc treatment (San Francisco AIDS Foundation
2006; Mindel and Tenant-Flowers, 2001; Bannister et al, 2000; Perelson and Nelson, 1999).
However, people with acute HIV infection usually do not test positive for HIV antibodies until
seroconversion, which commonly occurs between 6 to 12 weeks after infection is complete
(San Francisco AIDS Foundation 2006; Piot and Colebunders, 1987). The latent phase of
HIV infection succeeds seroconversion. After seroconversion, the concentration of CD4+
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T cells in the blood usually increases again and declines gradually during the latent phase
(Lewthwaite and Wilkins, 2005; Bannister et al, 2000; Perelson and Nelson, 1999). Also after
seroconversion, the viral load in the blood falls to a much lower level called the `set point'
and remains relatively constant during the latent phase of HIV infection (Lewthwaite and
Wilkins, 2005; Mindel and Tenant-Flowers, 2001; Bannister et al, 2000; Perelson and Nelson,
1999). Although, HIV antibodies continue to be detectable in the blood, for much of the
latent phase the infected person looks and feels completely well and is not unduly susceptible
to infections (San Francisco AIDS Foundation 2006; Bannister et al., 2000; Perelson and
Nelson, 1999). In the absence of treatment, it has been reported that the latent phase of
HIV infection lasts from 18 months to 15 years or more (Bannister et al, 2000; Callaway et al.,
1999). A substantial reduction in the concentration of CD4+ T cells and increase in the viral
load marks the end of the latent phase and the beginning of the symptomatic HIV infection
phase (Bannister et al, 2000). During the early and medium stages of the symptomatic HIV
infection phase, many people begin to experience some mild HIV infection symptoms, such
as skin rashes, fatigue, night sweats, slight weight loss, mouth ulcers, and fungal skin and
nail infections (San Francisco AIDS Foundation 2006; Piot and Colebunders, 1987). In the
late stage of the symptomatic HIV infection phase called AIDS, the damage to the immune
system is more severe. CD4+ T cell count falls below 200 cells per micro liter (Callaway
et al., 1999) and viral load in the blood reaches above 10 000 genome copies per milliliter
(Bannister et al, 2000). The overall weakness of the immune system during the late stage
of the symptomatic HIV infection phase allows the establishment of opportunistic infections
such as Pneumocystis carinii pneumonia, Mycobacterium avium complex disease, Kaposi's
sarcoma, cytomegalovirus, toxoplasmosis, and candidiasis which eventually lead to death
(San Francisco AIDS Foundation 2006; Bannister et al, 2000; Callaway et al., 1999; Piot and
Colebunders, 1987). The course of HIV infection described above is summarized in Figure
2.1.
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Figure 2.1: Stages of HIV infection.
Source: http://msl.cs.uiuc.edu/∼yershova/bcb495/bcbProject-3_ﬁles/image015.gif.
Accessed on 20 June 2007.
2.2 Global HIV/AIDS situation
Since the ﬁrst AIDS cases were reported among a few gay men in the United States of
America quarter a century ago, AIDS has grown into a global epidemic in nearly every
country worldwide. According to UNAIDS (2006), HIV has globally now infected more than
65 million people of whom an estimated 25 million people have died. In 2005 alone, an
estimated 2.8 million people lost their lives to AIDS, 4.1 million people were newly infected
with HIV and 38.6 million people were living with HIV worldwide.
Although the HIV/AIDS epidemic has emerged into a global epidemic, it is inaccurate to
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speak of a single global HIV/AIDS epidemic. The HIV/AIDS epidemic has disproportion-
ately aﬀected certain geographic regions (for example, SSA and the Caribbean) and sub-
populations (for example, women in SSA, men who have sex with men (MSM), injecting drug
users (IDUs), and sex workers). Therefore, when assessing the global HIV/AIDS situation,
it is important to take this heterogeneity into account. In the next paragraphs we present
a summary of current HIV/AIDS trends in selected regions of the world based on the 2006
UNAIDS Report on the Global AIDS Epidemic and a report published on the eve of the 16th
International AIDS Conference (August 13-18, 2006, in Toronto, Canada) in the Morbidity
and Mortality Weekly Report by CDC.
Currently, SSA is rated as the world's most severely HIV/AIDS aﬀected region because
it has just over 10% of the total world's population but it is home to about 64% of all
the people living with HIV in the world. The HIV/AIDS epidemic is suspected to have
probably began in SSA about 75 years ago after some people who ate wild chimpanzees in
Cameroon became infected with a low-virulence progenitor of the virus that causes AIDS
(Will, 2006). The primarily mode through which HIV is transmitted among adults in this
region is heterosexual contact (Buvé et al., 2002) and all the countries except Angola have
an estimated HIV prevalence rate of more than 10 percent among adults aged 15 to 49 years.
In 2005, an estimated 3.2 million people in the SSA region became newly infected with HIV,
while 2.4 million people died of AIDS. The region also has more HIV infected women than
men. In 2005, it was estimated that 4.6% of female youth aged 15-24 years were living with
HIV compared to 1.7% of males of the same age group.
In SSA, the HIV/AIDS crisis is more severe in southern Africa- the epicenter of the
HIV/AIDS epidemic. In Botswana, Lesotho, Swaziland and Zimbabwe, the estimated adult
HIV prevalence rates are above 20%. In South Africa, the HIV/AIDS epidemic shows no
evidence of abating. In 2005, South Africa had an estimated HIV prevalence rate of 18.8%
in adults aged 15-49 years. It has also been estimated that there were 5.5 million people
living with HIV in South Africa in 2005. This ﬁgure positioned South Africa as the country
with the largest number of people living with HIV in the world along with India in Asia.
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Despite remaining the world's severely HIV/AIDS aﬀected region, declines in adult HIV
prevalence have recently been observed in some countries in SSA. These countries are Kenya,
Uganda, Zimbabwe and urban areas of Burkina Faso. Nevertheless, AIDS related deaths
continue to rise in these countries.
In Asia, the HIV/AIDS epidemic is driven by sex workers, IDUs and MSM. Estimates for
2005 indicate that 8.3 million people of whom 2.4 million were adult women were living
with HIV in Asia. Further, in Asia, an estimated 180 000 children were living with HIV
and approximately 930 000 people were newly infected with HIV in 2005. So far, AIDS has
claimed approximately 600 000 lives in Asia.
The HIV/AIDS estimates from Asia also indicate that more than two-thirds (about 5.7
million people) of all the people living with HIV in Asia live in India. While approximately
80% of the HIV infections in India are acquired through heterosexual contact, in China
650 000 IDUs account for about half of the people living with HIV, and in Thailand and
Cambodia, the epidemic has largely been driven by commercial sex work. In Thailand, there
has been a decline in HIV prevalence in pregnant women from 2.4% in 1995 to 1.2% in 2003.
In contrast, HIV prevalence among MSM increased from 17% in 2003 to 28% in 2005.
Data from Eastern Europe and Central Asia indicate that the HIV/AIDS epidemic there is
also continuing to spread. In 2005 it was estimated that about quarter of a million people
were newly infected with HIV. This ﬁgure brought the total number of people living with
HIV in this region to 1.5 million.
In America, most of the HIV infections occur among MSM, IDUs and sex workers. Brazil,
the most populous country in the American continent after the United States had an
estimated adult HIV prevalence of 0.5% and was home to approximately 30% of all the
people living with HIV in South and Central America and the Caribbean in 2005. The
Caribbean is the second most severely HIV/AIDS aﬀected region after SSA and the epidemic
there is also largely spread through heterosexual intercourse. Recent data indicate that
national HIV prevalence rates in all the areas in the Caribbean except Haiti have remained
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constant.Recently, there has also been an increase in evidence of resurgent epidemics in the
United States of America and in some countries in Europe among MSM.
These statistics support the remark made by Elias A. Zerhouni and his colleagues from
the National Institute of Allergy and Infectious Diseases (NIAID) in their statement on the
25th Anniversary of the First Published Reports of AIDS on June 5, 2006 that AIDS is the
deadliest pandemic of our generation and one of the worst in human history (The Body,
2006). The HIV/AIDS epidemic has not spared any region, race, or social class of people
worldwide. Both the powerful and powerless in every society worldwide are aﬀected with
this lethal epidemic.
2.3 HIV/AIDS situation in Malawi
The ﬁrst AIDS cases in Malawi were diagnosed in 1985 (Avert, 2007; MEASURE Evaluation,
2004; Yoder and Matinga, 2004; NAC, 2003a). However, it has been argued that the 2%
HIV prevalence rate discovered among antenatal clinic attendees at Queen Elizabeth Central
Hospital in Blantyre in the southern region in that year suggests that the epidemic may have
started in Malawi as earlier as 1977 (Yoder and Matinga, 2004).
Like elsewhere in SSA, in Malawi HIV is predominantly spread through heterosexual
intercourse among the adult population and by vertical transmission to infants from HIV-
infected mothers (NAC, 2003b). During the ﬁrst decade of the HIV/AIDS epidemic in
Malawi, prevalence among women attending antenatal clinics (ANC) grew rapidly. By 1998,
26% of antenatal clinic attendees in urban areas tested HIV positive (MEASURE Evaluation,
2004). Recent trends indicate that the median HIV prevalence for all antenatal attendees
declined from 22.8% in 1999 to 16.9% in 2001, 17.0% in 2003 and 15.0% in 2005 (NAC,
2005). Although HIV prevalence rates remain high in urban areas compared to rural areas
(Avert, 2007; WHO, 2005b), recent trends also suggest that HIV prevalence is declining
in many urban areas and increasing in many rural ones (Avert, 2007; UNAIDS/WHO,
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2005). However, national estimates of HIV prevalence in the adult population are reported
to have remained constant since 1996 (NAC, 2005). Furthermore, HIV prevalence rates
are particularly highest among women aged between 13 and 24 years (Avert, 2007; WHO,
2005b; UNAIDS/WHO, 2005). As high levels of movement between urban, rural and mining
areas are important catalysts for the spread of HIV infection, the main drivers of the HIV
epidemic in Malawi are mobile groups, which include truck drivers, sex workers, ﬁshermen,
ﬁsh traders, migrant and seasonal workers, military personnel, prisoners and refugees (Avert,
2007; WHO, 2005b).
2.4 HIV/AIDS and child mortality
HIV/AIDS contributes to child mortality both directly and indirectly. Directly, HIV/AIDS
contributes to child mortality in the sense that children infected with HIV through
MTCT themselves die of AIDS (Brahmbhatt, 2006; Hecht et al., 2006; Newell et al.,
2004; Ng'weshemi et al., 2003; Adetunji, 2000; Peckham and Gibb, 1995). Indirectly,
HIV/AIDS contributes to child mortality in the sense that families and communities
weakened by HIV/AIDS render children more susceptible to illness and death from other
causes (International AIDS Vaccine Initiative, 2005). There are many possible ways through
which HIV/AIDS indirectly leads to negative health outcomes and consequently increased
mortality among children regardless of the children's HIV status. Some of these ways include
negative health impacts emanating from the death of or frequent illness of parents and care-
givers, loss of health workers either through illness and death from HIV/AIDS or attrition
of new workers from fear of infection and diversion of resources needed for provision of
health care services for children to purchase the expensive drugs needed for caring those
living with HIV/AIDS (Hecht et al., 2006; Ng'weshemi et al., 2003; Adetunji, 2000). Since
the focus of this study is not on the indirect eﬀects of HIV/AIDS on child mortality, we
do not present a detailed review of the many possible scenarios through which HIV/AIDS
indirectly contributes to child mortality. In the subsections that follow, we review various
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issues pertaining to how HIV/AIDS directly contributes to child mortality which include
available knowledge on acquisition of HIV infection in children, survival of HIV infected
children and ways of reducing HIV/AIDS attributable child mortality.
2.4.1 Acquisition of HIV infection in children
According to Newell et al. (2004) and De Cock et al. (2000), the epidemiology of HIV/AIDS
in children mirrors that among women of reproductive age. Children get infected with HIV
nearly always through MTCT which can occur during pregnacy (intrauterine transmission),
delivery (intrapartum transmission) and the breastfeeding period (postpartum transmission)
(Newell et al., 2004; Dabis et al., 2000; Newell, 1998).
There are various ways in which intrauterine HIV transmission can occur. According to
Newell (1998), intrauterine HIV transmission may occur through placental tears that would
result in transfusion of HIV infected blood from the mother to the fetal circulation through
either transplacental cellular traﬃc or by progressive infection of diﬀerent placental layers
until the virus reaches the fetoplacental circulation. Based on reviews by Newell (1998) and
Newell et al. (2004), the available evidence that supports intrauterine HIV transmission
indicates that infection is rare in early pregnancy but more common in late pregnancy.
Another review by De Cock et al. (2000) indicate that in the absence of breastfeeding,
intrauterine HIV transmission accounts for 30% of pediatric HIV infections and the remaining
70% of infant HIV infections occur during labour and delivery.
The available literature on intrapartum transmission indicates that during labour and
delivery, transmission of HIV infection could occur through direct contact of the fetus/infant
with HIV infected maternal blood and genital secretions during passage through the birth
canal, through ascending infection from the vagina or cervix to the fetal membranes
and amniotic ﬂuid, through absorption in the fetal-neonatal digestive tract, and through
maternal-fetal microtransfusion during uterine contractions in labour (Newell, 1998).
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Some of the risk factors for intrauterine and intrapartum transmission identiﬁed in the
literature include high maternal viral load, low maternal CD4+ T cell counts, advanced
maternal immune deﬁciency, long labour and prolonged membrane rupture (Newell et al.,
2004; De Cock et al., 2000; Newell, 1998; Peckham and Gibb, 1995). According to a review
by De Cock et al. (2000), in untreated nonbreastfeeding populations, cumulative rates of
HIV transmission during the intrauterine and intrapartum periods range from 14% to 32%.
Newell et al. (2004) report that breastfeeding approximately doubles the risk of HIV
transmission. Newell (1998) states that transmission of HIV through breast milk can occur
in situations where the mother becomes infected with HIV shortly after delivery as well as
in established maternal HIV infections. Although HIV transmission through breast milk
can occur at any point during lactation, the empirical evidence from epidemiologic cohort
studies and clinical trials reviewed by Fowler and Newell (2002) suggest higher transmission
risk in the ﬁrst six months of life compared with low rates in the second year of life. The
risk factors for postpartum transmission of HIV infection through breastfeeding include
maternal viral load in plasma and breast milk, HIV-related maternal immune status, breeding
nipples, subclinical and clinical mastitis and breast abscesses (UNICEF, UNAIDS, WHO and
UNFPA, 2004; Fowler and Newell, 2002). It has also been suggested that seroconversion of
the mother during lactation increases the risk of postpartum transmission of HIV infection
through breastfeeding (De Cock et al, 2000). In their review, De Cock et al. (2000) found
that among breastfeeding populations in resource poor settings cumulative transmission rates
of HIV infection range from 25% to 48%.
2.4.2 Survival of HIV infected children
There is limited information regarding the survival status of children who acquire HIV
infection from their mothers through MTCT. Very few community-based studies have
measured the HIV status of infants and tracked their survival because the persistence of
maternal antibodies in the blood of infants makes the standard ELISA HIV tests which are
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used for adults inappropriate for testing children and alternative polymerase chain reaction
(PCR) tests that can detect the presence of the virus (as opposed to HIV antibodies) are
very expensive and diﬃcult to administer outside of a hospital setting (Zaba et al., 2003).
As reported by The UNAIDS Reference Group on Estimates, Modelling and Projections
(2002), there is no information on long term survival of children infected with HIV via
MTCT. Most of the few studies that have measured the HIV status of infants (for instance,
a study in Blantyre, Malawi by Taha et al. (2000) and another study in the Gambia by Ota
et al. (2000)) have only tracked their survival up to around 24 to 36 months of life (The
UNAIDS Reference Group on Estimates, Modelling and Projections, 2002). Only one study
conducted in Kigali, Rwanda followed HIV-infected children until ﬁve years of age (Spira et
al., 1999).
After reviewing published and unpublished data of some of the studies on survival outcomes
of HIV infected children which included studies by Dabis et al. (2001) in Cote d'Ivoire and
Burkina Faso, Spira et al. (1999) in Rwanda, Lepage et al. (1998) in Uganda, Jean et al.
(1999) in Haiti and Bobat et al. (1999) in South Africa, The UNAIDS Reference Group
on Estimates, Modelling and Projections (2002) recommended that survival times for HIV
infected children up to 15 years of life be generated by a double Weibull distribution which
takes the form,
S(y) = 1− [p(1− exp(−(β1y)α1)) + (1− p)(1− exp(−(β2y)α2))] (2.1)
where S(y) represents the fraction of children who have not died from HIV-related causes y
years after birth, p is the proportion of children who progress to death rapidly, α1, β1, α2
and β2, are parameters of the component Weibull curves describing mortality amongst the
group of children that progress to death rapidly and the group of children that progress to
death slowly respectively (Zaba et al., 2003).
The above formulation of the survival curve for HIV infected children allows for two periods
of very high mortality: in infancy when HIV frequently overwhelms the immature immune
system, and after age nine, when it is assumed that the few remaining survivors will succumb
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to opportunistic infections and progress to AIDS in the same way as adults (The UNAIDS
Reference Group on Estimates, Modelling and Projections, 2002). Fitting of this curve to
the reviewed data suggested that by ﬁve years after birth 60% of HIV infected children would
be dead.
2.4.3 Reducing under-ﬁve mortality attributable to HIV/AIDS
According to Walker et al. (2002), HIV/AIDS attributable under-ﬁve mortality can be
reduced in three main ways. First is reduction of HIV prevalence in women of childbearing
age, second is prevention of unwanted pregnancies in HIV-infected women and third is direct
prevention of MTCT of HIV infection from infected mothers to their infants. Interventions
designed to reduce HIV prevalence in women of childbearing age are those that are also
intended to reduce the spread of HIV in the adult population and they include mass
media campaigns, promotion of voluntary counseling and testing, condom social marketing,
improved treatment for sexually transmitted infections and public sector condom promotion
and distribution (Johnson and Dorrington, 2006; Stover et al., 2002). Presently, the available
approaches to interventions to prevent MTCT of HIV infection only target the peripartum
period. Interventions demonstrated to be eﬀective include the reduction of maternal viral
load through antiretroviral therapy in pregnancy and during delivery, the avoidance of
exposure to contaminated maternal secretions through elective caesarean section delivery,
and the avoidance of breastfeeding (Newell et al., 2004). The available evidence indicate
that MTCT can be greatly reduced by the administration of zidovudine (ZDV) orally to
the woman initiated between 14 and 34 weeks of gestation, intravenously during labour
and orally to the neonate in the ﬁrst six weeks of life (Dabis et al., 2000; De Cock et al.,
2000). Reductions in transmission of one half to one third have been demonstrated in trials of
simpliﬁed ZDV regimens in Southeast Asia and SSA ( De Cock et al., 2000). Intrapartum and
neonatal single-dose of Nevirapine has also been demonstrated to achieve similar reductions
in MTCT as ZDV (Guay et al., 1999).
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2.5 Malawi's response to the HIV/AIDS epidemic and
eﬀorts to reduce under-ﬁve mortality attributable to
HIV/AIDS
Following the identiﬁcation of the ﬁrst AIDS cases, the Malawian government implemented a
number of policies, institutional and operational strategies aimed at containing the epidemic
and preventing new infections. These included the birth of the National AIDS Control
Programme (NACP) in 1989 and the formation of the Cabinet Committee on Health and
HIV/AIDS to provide policy and political direction to the Ministry of Health (Malawi HIV
and AIDS Monitoring and Evaluation Report 2005).
Between 1989 and 1993, only two major interventions were implemented in an eﬀort to
stop the spread of HIV/AIDS in Malawi. These interventions were a blood screening
policy and a strategy for health education about HIV/AIDS related risks and prevention
(MEASURE Evaluation, 2004). As the toll of HIV/AIDS started to grow, Malawi realized
the need to intensify its eﬀorts in ﬁghting the epidemic. By 1993, a multidisciplinary
approach that incorporated social, psychological, and economic dimensions into the response
to the epidemic was under development. The prevention and control strategies of
NACP were broadened and encompassed activities in surveillance, voluntary counseling
and testing, home-based care, information and education campaigns, behavioural change
communications, control of sexually transmitted diseases and research (ibid). NACP
also started to work with other stakeholders such as the private sector, nongovernmental
organizations, donors, religious organizations, community-based organizations and people
living with HIV/AIDS (ibid).
In 1996, an evaluation of the national response to the HIV/AIDS epidemic by the Malawian
government and its collaborating partners in the ﬁght against the epidemic found that
although there was high awareness of HIV and AIDS, there was little behaviour change
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and the epidemic continued to grow (Malawi HIV and AIDS Monitoring and Evaluation
Report 2005). It was therefore recommended that Malawi should develop a comprehensive
ﬁve-year plan to guide HIV and AIDS prevention, treatment and impact mitigation. This
resulted in the development of the Malawi National HIV/AIDS Strategic Framework (NSF)
in 1999. The NSF covered the period 2000 to 2004 and focused on prevention, advocacy, and
behavior change; treatment, care, and support; sectoral mainstreaming; impact mitigation;
and surveillance and monitoring. It also placed emphasis on the need for various stakeholders
including the private sector, and teaching institutions to take an active role in designing,
implementing, and monitoring the multi-sectoral and multidisciplinary HIV and AIDS
interventions in the country (ibid).
The 1996 evaluation of the national response to the HIV/AIDS epidemic in Malawi also
revealed that there was insuﬃcient coordination of planning, implementation, monitoring
and evaluation of the activities of various agencies involved in the ﬁght against the epidemic
and highlighted lack of adequate support to NACP and over-reliance on the health sector for
the national response (ibid). In response, with an aim to improve the multisectoral national
response, the Malawian government, together with the stakeholders established the National
AIDS Commission in July 2001 within the Oﬃce of the President and Cabinet to replace
NACP. Since its establishment, NAC has been coordinating the multisectoral implementation
of the national response and its operations are monitored by a board of commissioners drawn
from government, nongovernmental organizations, religious organizations and the private
sector (ibid).
Another important step in reorganising the national eﬀorts to ﬁght the HIV/AIDS epidemic
in Malawi was the development the national AIDS policy in 2003. The policy stipulates the
guiding principles for all national HIV/AIDS programmes and interventions (WHO, 2005b;
Malawi HIV and AIDS Monitoring and Evaluation Report 2005; NAC 2003a).
As a consequence of the multi-sectoral and multidisciplinary approach to the ﬁght against
the HIV epidemic, Malawi has several public, private, community-based and faith-based
organisations involved in various HIV/AIDS programmes and interventions that either aim
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at preventing the further spread of HIV infection or mitigating the impact of HIV/AIDS on
the socioeconomic status of individuals, families, communities and the nation as stipulated in
the National HIV/AIDS policy. These organisations have had a positive impact in raising the
levels of awareness about HIV/AIDS in Malawi. Findings from the 2004 Malawi DHS (NSO
and ORC Macro, 2005) and the ﬁrst behavioural surveillance survey conducted in Malawi in
2004 (NAC et al., 2004) indicate that almost every one aged 15 years and above in Malawi has
heard about HIV/AIDS. Despite the universal knowledge about the existence of HIV/AIDS
these two national surveys found that misconceptions about how HIV is transmitted and
how HIV infection can be prevented still exist in Malawi. The ﬁndings from the two surveys
further indicate that the various organisations involved in HIV/AIDS prevention programmes
have not substantially impacted on behaviour change. The progress achieved in adoption of
risk-reducing behaviour such as premarital sexual abstinence, limiting the number of sexual
partners and consistent condom use with causal partners is not very impressive.
Part of the eﬀorts to mitigate the impact of HIV/AIDS in Malawi has been the provision
of free antiretroviral treatment to HIV-infected individuals in the public sector since 2003
(WHO, 2005b). During the intervening years huge progress has been achieved in scaling
up treatment. There has been a dramatic rise in the number of HIV-infected individuals
receiving antiretroviral treatment from 4 000 individuals by December, 2003 to 81 000
individuals by December, 2006 (Avert, 2007; WHO et al, 2007; WHO, 2005b). The number
of sites providing free antiretroviral treatment in the public sector has also been growing
exponentially. As of December, 2006 there were 104 sites providing free antiretroviral
treatment to eligible HIV-infected patients.
Apart from the HIV/AIDS prevention programmes aimed at primary prevention of HIV
infection among women, government and some private and non-governmental organizations
have recently become involved in the provision of services aimed at preventing MTCT of HIV
infection as part of eﬀorts to reduce under-ﬁve mortality directly attributable to HIV/AIDS
in Malawi. Beginning 2002, HIV-infected pregnant women in Malawi have been receiving
single-dose Nevirapine to prevent them from passing the infection to their infants. According
to the Malawi HIV and AIDS Monitoring and Evaluation Report 2005, the number of sites
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providing PMTCT services increased from 9 sites in 2002 to 36 sites by end of 2004. The
number of HIV-infected pregnant women receiving NVP also increased from 2 198 in 2003 to
2 719 in 2004 and 5 054 in 2005 (Malawi HIV and AIDS Monitoring and Evaluation Report
2005, Ministry of Health, Lighthouse Trust (Lilongwe) and CDC (Malawi), 2006).
Malawi's eﬀorts to ﬁght the HIV/AIDS epidemic are supported by ﬁnancial assistance from
a number of international donors some of which include the World Health Organisation,
UNAIDS, the President's Emergency Plan for AIDS Relief (PEPFAR), the Global Fund
to Fight AIDS, Tuberculosis and Malaria, the World Bank Multi-Country HIV/AIDS
Programme (MAP), the United States Agency for International Development, the United
States Centers for Disease Control and Prevention, the United Kingdom Department for
International Development and Medecins San Frontiers.
In summary, Malawi has come a long way in putting in place strategies to combat the
HIV/AIDS epidemic. Several interventions and programmes have been put in place to halt
the spread of the epidemic and mitigate its impact including HIV/AIDS attributable under-
ﬁve mortality. It is obvious that the impact of the strategies and interventions recently
incorporated in the response to the HIV/AIDS epidemic on the trajectory of the epidemic
and its impact on the Malawian population would be seen in the years to come. However,
there is need to estimate the extent to which these strategies and interventions would reduce
the HIV/AIDS burden in Malawi. It is for this reason that this study attempts to examine
the extent to which the current PMTCT programmes in Malawi would help in reaching the
country's overall under-ﬁve mortality reduction goals.
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Chapter 3
Research design and methodology
This study did not involve collection of new data but used some of the existing indirect
methods and procedures, including mathematical models to derive estimates of the
proportion of under-ﬁve mortality directly attributable to HIV/AIDS in Malawi during the
period 2000 to 2004. To a larger extent, the study adopted the methods and procedures that
have been used by a number of researchers worldwide and recommended by UNAIDS and
WHO. In this chapter we present details of the methods and procedures used in this study.
3.1 Methodology
This study is subdivided into seven major parts. The ﬁrst part involves estimating the
prevalence of HIV among women aged 15-49 in Malawi for the period 1999 to 2004. The
second part involves estimating the number of women in the reproductive age (15-49 years)
in Malawi for the period 1999 to 2004. The third part involves applying the estimated
HIV prevalence ﬁgures to the estimated number of women of reproductive age to estimate
the number of HIV infected women. The fourth part involves applying estimates of age-
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speciﬁc fertility rates to the estimated number of women of reproductive age to estimate
the number of children born in each year. The ﬁfth part involves applying mother-to-child
transmission (MTCT) rates to the estimated number of children born to HIV infected women
to estimate the number of children infected with HIV through MTCT. The sixth part involves
applying children's HIV survival distributions to estimate the number of children dying due
to HIV/AIDS before their ﬁfth birthday in Malawi during the period 2000 to 2004. In
the last part, the estimated number of children dying due to HIV/AIDS before their ﬁfth
birthday during the period 2000 to 2004 is used together with the total number of estimated
birth from 2000 to 2004 to estimate the proportion of under-ﬁve mortality that is directly
attributable to HIV/AIDS in Malawi for the period 2000 to 2004. What follows are detailed
descriptions of the methods and procedures that have been used in each of the stated parts.
3.1.1 Estimating HIV prevalence among women of reproductive age
Estimates of HIV prevalence among women of reproductive age were largely based on ANC
sentinel surveillance data collected in Malawi from 1999 to 2005. In developing countries
with generalised epidemics (deﬁned as a prevalence of at least 1% among pregnant women
attending antenatal clinics) like Malawi, HIV prevalence among pregnant women is assumed
to be a good approximation of HIV prevalence among the general adult population (15-49
years) (WHO and UNAIDS 2003, The UNAIDS Reference Group on Estimates, Models
and Projections, 2003). However, ANC surveillance systems are associated with a number
of limitations. First, there is high level of diversity in sample sizes among the sites
which can result in under-or over-representation of prevalence (Rhucharoenpornpanich and
Chamratrithirong, 2001). Second, sites classiﬁed as rural are located in small towns and
largest rural settlements with higher levels of economic activity and mobility and probably
also associated with higher HIV prevalence, therefore may over-estimate prevalence in most
remote areas (Schwartlander et al., 1999; WHO and UNAIDS, 2003; The UNAIDS Reference
Group on Estimates, Models and Projections, 2003). Third, since testing is only done to
those women in the general population who become pregnant, the prevalence from ANC
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surveillance may over-estimate the prevalence in the general population as pregnant women
may be having unprotected sex at a greater rate than women in the general population. In
addition, the prevalence in ANC attendees may under-estimate the prevalence in the general
population because women with HIV associated infertility are not captured (NSO and ORC
Macro, 2005).
In order to minimise some of the stated sources of bias that are inherent in the ANC
sentinel surveillance system, some adjustments are made to the ANC surveillance data when
estimating HIV prevalence for all adults. In this section, we describe the procedure that was
used in this study to adjust the existing ANC surveillance data in estimating HIV prevalence
among women of reproductive age in Malawi from 1999 to 2005.
A number of steps were involved in estimating the HIV prevalence among women of
reproductive age. First, we analysed available ANC sentinel surveillance data for the years
1999 to 2005 to obtain unadjusted age-speciﬁc HIV prevalence ﬁgures among women visiting
ANCs in Malawi for the years 1999 to 2005. Although the ANC sentinel sites in Malawi are
classiﬁed into three categories (urban, semi-urban and rural), in this study they were only
split into two categories: urban and non-urban sites (semi-urban and rural sites). Thus,
from the analysis we obtained separate age speciﬁc HIV prevalence ﬁgures for aggregated
urban sites and aggregated non-urban sites. These HIV prevalence rates were used as initial
estimates of HIV prevalence in each of the two ANC site categories.
Ninety ﬁve percent conﬁdence intervals were calculated for the age speciﬁc HIV prevalence
estimates for each site category obtained above using the adjusted Wald method proposed
by Agresti and Coull (1998). The choice of this method was motivated by the fact that it is
relatively simple to compute and has been demonstrated to provide the best average coverage
even for very small sample sizes than the other methods of calculating binomial conﬁdence
intervals (Agresti and Coull, 1998; Sauro and Lewis, 2005). The adjusted Wald method
uses the usual simple Wald formula but is "adjusted" in that it adds half of the squared
Z-critical value to the numerator and the entire squared critical value to the denominator
before computing the interval. Thus, the adjusted Wald method computes the 100(1− α)%
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conﬁdence interval for p as
pˆ± z
α/2
√
pˆ(1− pˆ)
N
(3.1)
where pˆ =
x+
z2
α/2
2
N
, N = n+ z2
α/2
, x denotes a binomial variate, n denotes the sample size and
zc denotes the 1− c quantile of the standard normal distribution (Agresti and Coull, 1998;
Sauro and Lewis, 2005).
Second, the initial HIV prevalence estimates were then adjusted for representativeness by
lowering the estimated prevalence in the aggregated non-urban clinic sites. Consistent with
the WHO/UNAIDS approach, the adjusted estimate of HIV prevalence in the non-urban
sites are equal to 80% of the initial HIV prevalence estimates obtained in the ﬁrst step above
(The UNAIDS Reference Group on Estimates, Models and Projections, 2003).
Third, we calculated national estimates of age speciﬁc HIV prevalence among women based
on ANC surveillance data by applying the age speciﬁc female population size by urban and
rural residence. Table 3.1 shows the population of females of reproductive age in urban and
rural areas by ﬁve year age groups in Malawi as observed in the two most recent censuses.
Based on Table 3.1 the percentage of the female population that was in the urban areas in
1987 and 1998 and the annual increase in the urban population assuming a constant annual
increase during this period is shown in Table 3.2.
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Table 3.1: Urban and rural female populations in Malawi
1987 1998
Age group Urban Rural Urban Rural
15-19 44 637 357900 91196 468875
20-24 46 730 323 389 96 051 447 871
25-29 38 218 270 584 66 409 332 143
30-34 24 726 204 494 44 386 253 775
35-39 20 398 201 303 32 333 213 451
40-44 11 803 139 778 20 149 160 393
45-49 8 894 127 287 15 382 151 116
Source: NSO (1993; 2000)
Table 3.2: Percent of urban and rural female populations in Malawi
% Urban
Age group 1987 1998 Annual % increase
15-19 11.1 16.3 0.5
20-24 12.6 17.7 0.5
25-29 12.4 16.7 0.4
30-34 10.8 14.9 0.4
35-39 9.2 13.2 0.4
40-49 7.2 10.2 0.3
Source: Computed by author.
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Again assuming constant annual increases, the annual increases in age speciﬁc urban female
population presented in Table 3.2 were used to calculate estimates of the percentage of
female population in the urban and the rural areas in Malawi for the years 1999 to 2005.
The calculated estimates of the percentage of urban and rural populations were applied to
the HIV prevalence ﬁgures in aggregated urban sites and the adjusted HIV prevalence ﬁgures
in aggregated non-urban sites to obtain national estimates of HIV prevalence among females.
The national estimate of HIV prevalence for females aged a in year y were calculated using
the following formula:
HIV_Ntn
f,a,y
= (HIV_Ubn
f,a,y
× Prop_Ubn
f,a,y
) + (HIV_Rl_Adj
f,a,y
× Prop_Rl
f,a,y
)
(3.2)
where HIV_Ntn
f,a,y
denotes the estimated national HIV prevalence for females in age group
a in year y based on ANC data, HIV_Ubn
f,a,y
denotes the estimated HIV prevalence for
females in age group a in year y in aggregated urban sites, Prop_Ubn
f,a,y
denotes the
estimated percentage of females in urban areas in age group a in year y, HIV_Rl_Adj
f,a,y
denotes the adjusted estimate of HIV prevalence for females in age group a in year y
in aggregated non-urban sites and Prop_Rl
f,a,y
= (100% − Prop_Ubn
f,a,y
) denotes the
estimated percent of females in non-urban areas in age group a in year y.
Since 1999, ANC sentinel surveillance surveys were only conducted in Malawi every two years.
Therefore, after obtaining the national age speciﬁc estimates of HIV prevalence for females
based on ANC surveillance data, prevalence ﬁgures for the years in which the surveys were
not conducted were interpolated from these results. Age speciﬁc estimates of HIV prevalence
for each year in which the survey was not done were calculated as the average of the national
age speciﬁc estimates of HIV prevalence in the preceding and succeeding year. Thus, the
formula:
HIV_Ntn
f,a,y
=
1
2
(HIV_Ntn
f,a,y−1 +HIV_Ntnf,a,y+1) (3.3)
was used to estimate national age speciﬁc HIV prevalence ﬁgures for females in Malawi for
the years in which ANC sentinel surveillance surveys were not conducted.
Thereafter, the national age speciﬁc estimates of HIV prevalence for females for 2004 based
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on the ANC sentinel surveillance data were compared with the age speciﬁc estimate of
HIV prevalence from the 2004 MDHS and age speciﬁc ratio of ANC to general population
HIV prevalence for Malawi was obtained. Lastly, the age speciﬁc ratio of ANC to general
population HIV prevalence was used to further adjust the national age speciﬁc estimates of
HIV prevalence for females based on the ANC surveillance data to obtain ﬁnal estimates of
national HIV prevalence for females in age group a in year y for the years from 1999 to 2005
denoted as HIV_prevalence
f ,a,y.
3.1.2 Estimating the number of women of reproductive age
Since our interest was in estimating the number of children that died of HIV/AIDS before
the age of ﬁve years during the period 2000 to 2004, we required the number of children
born during the period 2000 to 2004 that acquired HIV infection from theirs mothers. This
entailed that we also needed the number of women of reproductive age in those years. The
number of women in the 15-49 age group for the years in question was projected from the
results of the 1998 census which was conducted from 1st to 21st September 1998. According to
the analytic report of the 1998 Malawi census (NSO, 2002), an evaluation of age data showed
that the age distribution were distorted by age misreporting. Therefore, in this study we
took the age-smoothed population distribution of females as the base year population and
then projected this population using the methodology that is used in the mathematical
model that is implemented in the DemProj computer program. This model is based on the
standard cohort component projection model that has been modiﬁed to produce single year
projections (Stover and Kirmeyer, 2004).
Consistent with the methodology in the DemProj computer program, we started the
projection by separating the age-smoothed base year population in ﬁve-year age groups
from 5-9 to 45-49 into single years of age using the Beers formulae (ibid). The 5-9 age group
was splitted using the following formulae:
a5 = 0.0404 ∗ p1 + 0.2000 ∗ p2 − 0.0344 ∗ p3 − 0.0128 ∗ p4 + 0.0068 ∗ p5 (3.4)
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a6 = 0.0093 ∗ p1 + 0.2268 ∗ p2 − 0.0402 ∗ p3 + 0.0028 ∗ p4 + 0.0013 ∗ p5 (3.5)
a7 = −0.0108 ∗ p1 + 0.2272 ∗ p2 − 0.0248 ∗ p3 + 0.0112 ∗ p4 − 0.0028 ∗ p5 (3.6)
a8 = −0.0198 ∗ p1 + 0.1992 ∗ p2 + 0.0172 ∗ p3 + 0.0072 ∗ p4 − 0.0038 ∗ p5 (3.7)
a9 = −0.0191 ∗ p1 + 0.1468 ∗ p2 + 0.0822 ∗ p3 − 0.0084 ∗ p4 − 0.0015 ∗ p5 (3.8)
where p1, p2, p3, p4 and p5 refer to the population aged 0-4, 5-9, 10-14, 15-19, and 20-24
respectively and a5, a6, a7, a8 and a9 refer to the population at single ages 5, 6, 7, 8, and 9
respectively.
The age groups 10-14 to 45-49 were splitted using the following formulae:
a1 = −0.0117 ∗ pa−2 + 0.0804 ∗ pa−1 + 0.1570 ∗ pa − 0.0284 ∗ pa+1 + 0.0027 ∗ pa+2(3.9)
a2 = −0.0020 ∗ pa−2 + 0.0160 ∗ pa−1 + 0.2200 ∗ pa − 0.0400 ∗ pa+1 + 0.0060 ∗ pa+2(3.10)
a3 = 0.0050 ∗ pa−2 − 0.0280 ∗ pa−1 + 0.2460 ∗ pa − 0.0280 ∗ pa+1 + 0.0050 ∗ pa+2 (3.11)
a4 = 0.0060 ∗ pa−2 − 0.0400 ∗ pa−1 + 0.2200 ∗ pa + 0.0160 ∗ pa+1 − 0.0020 ∗ pa+2 (3.12)
a5 = 0.0027 ∗ pa−2 − 0.0284 ∗ pa−1 + 0.1570 ∗ pa + 0.0804 ∗ pa+1 − 0.0117 ∗ pa+2 (3.13)
where a1, a2, a3, a4 and a5 denote the ﬁrst, second, third, fourth and ﬁfth ages in the
particular age group and pa+i, (i = {−2, ..., 2}) is the population of age group i groups older
than the reference group.
For each year, the methodology in the DemProj computer program calculates the population
of females aged a using the formula:
Pop
f,a,y
=
(
Pop
f,a−1,y−1 +
Migr
f,a−1,y−1
2
)
× S
f,a−1,y−1 (3.14)
where Pop
f,a,y
is the population of females aged a in year y, Migr
f,a−1,y−1 is the net number
of migrants that were aged a−1 in year y−1 and S
f,a−1,y−1 is the survival ratio or proportion
of the female population aged a− 1 in year y − 1 that survive to age a in year y.
However, migration data were not collected in the 1998 census. So, like in the projections
done by the Malawi National Statistical Oﬃce for the period 1999 to 2023, in this study net
migration was assumed to be zero. Therefore, the population of females aged a in year y
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was calculated as:
Pop
f,a,y
=
(
Pop
f,a−1,y−1
)× S
f,a−1,y−1 (3.15)
The survival ratios in the model implemented in the DemProj computer program are derived
from model life tables (MLTs) which, for ages older than ﬁve years, provide ﬁve-year survival
ratios. According to Stover and Kirmeyer (2004), these ﬁve-year survival ratios are by
deﬁnition the proportion of the population of a particular ﬁve-year age group that survives
to the next ﬁve-year age group ﬁve years later. In the model these ﬁve-year survival ratios are
converted to single-year survival ratios by taking the ﬁfth root of the ﬁve-year survival ratios.
Thereafter, the result is used as the survival ratio for all the ﬁve ages in the corresponding
age group. The MLTs used in DemProj computer program are the four families of Coale-
Demeny MLT system (North, South, East, and West) and the ﬁve families of United Nations
MLT system (Latin America, Chile, South Asia, East Asia and General).
In the case of Malawi, choosing the appropriate MLT from which to derive the survival ratios
required in equation 3.15 among the existing MLTs is a challenge because there is more than
one MLT that is asserted to ﬁt the Malawian mortality experience. NSO (2002) indicates
that comparison analyses between the reported probability of dying between exact ages x
and x+n, nqx , values in the 1998 census with the corresponding values in the ﬁve families of
the United Nations MLT system as well as in the four families of Coale-Denemy MLT system
suggested that the north family of Coale-Denemy MLT system was more suitable to represent
mortality conditions in Malawi. On the contrary, in preparing the national estimates of
HIV/AIDS for Malawi in 2003, the Malawi National AIDS Commission used the South family
of Coale-Denemy MLT system (NAC, 2003b). The DemProj computer package also provides
the South family of Coale-Denemy MLT system as the default MLT for Malawi. In addition,
there is also a set of MLTs for Malawi that have been constructed by WHO and are available
online at http://www.who.int/whosis/database/life_tables/life_tables.cfm. Furthermore,
Doctor (2004) reports that comparison analyses of the pattern in age speciﬁc death rates in
Malawi during the 1987-1998 intercensal period with the corresponding age speciﬁc death
rates from 17 model patterns of mortality: four patterns from the regional MLTs of Coale
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and Demeny, ﬁve patterns based upon the United Nations MLTs, seven patterns based upon
the INDEPTH mortality patterns and one pattern based upon the WHO MLT for 2000 using
data from 1987 and 1998 Malawi censuses revealed that the best-ﬁtting model for females in
Malawi was Pattern 3 of INDEPTH mortality patterns.
Faced with the challenge of choosing the best MLT from which to derive the survival ratios
required in equation 3.15, the approach adopted in this study was to use survival ratios
derived from all the four MLTs asserted to ﬁt the Malawian mortality experience. Since,
according to INDEPTH Network (2002), Pattern 3 of INDEPTH mortality patterns is most
similar to the Far East family of the United Nations MLT system, the United Nations Far
East MLT was used instead of Pattern 3 of INDEPTH mortality patterns. The survival
ratios used in this study were therefore derived from Coale-Demeny north, Coale-Demeny
south, United Nations Far East and WHO MLTs. While the WHO MLT is based on data
that include the inﬂuence of HIV/AIDS on mortality, as pointed out by INDEPTH Network
(2002), the Coale-Demeny and the United Nations families of MLT Systems do not contain
an AIDS pattern of mortality, therefore Coale-Demeny north and Coale-Demeny south MLTs
may overestimate the annual number of women of reproductive age. Hence, the decision to
use the four MLTs was made with an intention to produce alternative estimates of the number
of women of reproductive age in Malawi that include all possible scenarios.
The WHO MLT for females in Malawi for the period 2000-2004 is shown in Table 3.3 and
the survival ratios corresponding to life expectancy values of 35 to 60 for females for the
other three MLTs are presented in Tables 3.4 to 3.6. These survival ratios were obtained
from ﬁles called "Cdnorth.f ", "Cdsouth.f " and "Unea.f " respectively that are contained in
a folder named "DP" that comes along with the Spectrum Projection Package.
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Table 3.3: WHO MLT for females in Malawi, 2000-2004
Age range nMx nqx lx ndx nLx Tx ex
<1 0.11583 0.10714 100000 10714 92500 4149713 41.5
1-4 0.01896 0.07255 89286 6477 341597 4057213 45.4
5-9 0.00607 0.02988 82808 2474 407856 3715616 44.9
10-14 0.00274 0.01363 80334 1095 398935 3307760 41.2
15-19 0.00288 0.0143 79240 1133 393364 2908825 36.7
20-24 0.00867 0.04243 78106 3314 382246 2515461 32.2
25-29 0.01874 0.08952 74792 6695 357223 2133216 28.5
30-34 0.03003 0.13968 68097 9512 316704 1775993 26.1
35-39 0.03438 0.15829 58585 9273 269741 1459289 24.9
40-44 0.03201 0.1482 49311 7308 228288 1189548 24.1
45-49 0.02888 0.13467 42004 5657 195877 961260 22.9
50-54 0.02132 0.10122 36347 3679 172538 765383 21.1
55-59 0.02606 0.12231 32668 3996 153351 592845 18.1
60-64 0.02942 0.13704 28672 3929 133539 439494 15.3
65-69 0.04236 0.19153 24743 4739 111868 305956 12.4
70-74 0.06384 0.27528 20004 5507 86253 194088 9.7
75-79 0.09712 0.39074 14497 5665 58325 107835 7.4
80-84 0.14607 0.53498 8833 4725 32350 49510 5.6
85-89 0.21453 0.6982 4107 2868 13367 17160 4.2
90-94 0.30655 0.79845 1240 990 3229 3793 3.1
95-99 0.426 0.85508 250 214 501 564 2.3
100+ 0.57571 1 36 36 63 63 1.7
Source: Life Tables for WHO Member States
http://www.who.int/whosis/database/life_tables/life_tables.cfm
Accessed on 10 October, 2007.
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Table 3.4: Survival ratios of females from Coale-Demeny north model life table
35.000 40.000 45.000 50.000 55.000 60.000
0.811960 0.843080 0.870220 0.893980 0.914530 0.933720
0.930896 0.943469 0.954425 0.964720 0.974971 0.983186
0.954290 0.963114 0.970610 0.977482 0.983771 0.988791
0.963857 0.971100 0.977138 0.982622 0.987368 0.991165
0.971520 0.977391 0.982240 0.986564 0.990093 0.992931
0.758770 0.797710 0.832410 0.864100 0.892330 0.917840
0.854730 0.881820 0.905100 0.926500 0.946680 0.963230
0.948300 0.957700 0.965850 0.973280 0.980240 0.986030
0.960920 0.967610 0.973440 0.978510 0.983360 0.987640
0.957450 0.964390 0.970440 0.975530 0.980490 0.985000
0.951020 0.958860 0.965700 0.971420 0.976960 0.982060
0.943020 0.952240 0.960280 0.967060 0.973470 0.979400
0.934210 0.944940 0.954300 0.962260 0.969600 0.976400
0.926880 0.938490 0.948620 0.957170 0.964890 0.971700
0.921190 0.933120 0.943530 0.952250 0.959850 0.967230
0.910300 0.923060 0.934190 0.943520 0.951330 0.959090
0.885930 0.901490 0.915080 0.926570 0.935860 0.945220
0.843440 0.864090 0.882150 0.897530 0.909630 0.921940
0.778010 0.805190 0.828980 0.849090 0.864830 0.881040
0.684210 0.719330 0.750110 0.775990 0.796070 0.817000
0.558590 0.601210 0.638650 0.670120 0.694090 0.719390
0.411150 0.458760 0.501170 0.537230 0.564660 0.594040
0.238430 0.267770 0.295010 0.318960 0.337690 0.358230
Source: Spectrum software version 2.39.
http://www.unaids.org/en/HIV_data/Epidemiology/episoftware.asp.
Accessed on 15 August, 2007.
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Table 3.5: Survival ratios of females from Coale-Demeny south model life table
35.000 40.000 45.000 50.000 55.000 60.000
0.801360 0.827480 0.849370 0.869030 0.887640 0.905090
0.888564 0.909569 0.928806 0.945698 0.960209 0.973030
0.942252 0.954228 0.964710 0.973559 0.980923 0.987146
0.967642 0.974673 0.980685 0.985652 0.989738 0.993075
0.980993 0.985243 0.988812 0.991732 0.994103 0.995969
0.724450 0.763460 0.798420 0.830200 0.859590 0.886540
0.855300 0.883750 0.909060 0.930510 0.948680 0.964530
0.964550 0.971550 0.978090 0.983600 0.988280 0.992330
0.968120 0.974050 0.979320 0.984180 0.988350 0.991980
0.958240 0.965820 0.972500 0.978760 0.984170 0.988880
0.951470 0.960140 0.967730 0.974820 0.981000 0.986410
0.948400 0.957490 0.965420 0.972750 0.979190 0.984890
0.945670 0.955080 0.963230 0.970670 0.977290 0.983210
0.942820 0.952250 0.960300 0.967660 0.974310 0.980320
0.939350 0.948630 0.956440 0.963560 0.970120 0.976140
0.927620 0.937960 0.946670 0.954430 0.961700 0.968480
0.903250 0.916470 0.927610 0.937430 0.946720 0.955430
0.856870 0.875870 0.891890 0.905970 0.919370 0.932000
0.782020 0.809340 0.832240 0.852420 0.871750 0.890090
0.677510 0.713060 0.742350 0.768630 0.794110 0.818530
0.530860 0.573360 0.607940 0.639160 0.669830 0.699610
0.365560 0.412220 0.450520 0.485370 0.520260 0.554740
0.211520 0.238610 0.262580 0.284730 0.307600 0.330870
Source: Spectrum software version 2.39.
http://www.unaids.org/en/HIV_data/Epidemiology/episoftware.asp.
Accessed on 15 August, 2007.
38
Table 3.6: Survival ratios of females from UN Far East model life table
35.000 40.000 45.000 50.000 55.000 60.000
0.854070 0.873810 0.892000 0.909000 0.925020 0.940150
0.946773 0.958744 0.968621 0.976799 0.983503 0.988895
0.969120 0.976568 0.982546 0.987330 0.991152 0.994149
0.979263 0.984403 0.988456 0.991684 0.994222 0.996202
0.984988 0.988738 0.991694 0.994019 0.995851 0.997274
0.812460 0.841740 0.867980 0.891350 0.912400 0.931630
0.912680 0.932470 0.948540 0.962050 0.973260 0.982150
0.966600 0.974780 0.981250 0.986400 0.990500 0.993700
0.958170 0.968400 0.976520 0.983000 0.988150 0.992170
0.926650 0.944570 0.958890 0.970350 0.979450 0.986550
0.908920 0.930380 0.947780 0.961900 0.973280 0.982270
0.900350 0.922490 0.940780 0.955930 0.968410 0.978510
0.894430 0.916080 0.934370 0.949890 0.963020 0.973990
0.890040 0.909900 0.927180 0.942350 0.955680 0.967320
0.880100 0.898690 0.915380 0.930540 0.944400 0.957050
0.855870 0.875220 0.893070 0.909760 0.925510 0.940400
0.817460 0.838860 0.859060 0.878440 0.897230 0.915530
0.766770 0.790390 0.813200 0.835610 0.857910 0.880270
0.705470 0.730350 0.754950 0.779730 0.805070 0.831280
0.628230 0.653740 0.679570 0.706250 0.734310 0.764240
0.530040 0.556340 0.583590 0.612440 0.643600 0.677840
0.407740 0.429760 0.452600 0.476220 0.501610 0.529790
0.236550 0.250550 0.263750 0.281130 0.297720 0.316340
Source: Spectrum software version 2.39.
http://www.unaids.org/en/HIV_data/Epidemiology/episoftware.asp.
Accessed on 15 August, 2007.
39
As described by Stover and Kirmeyer (2005), the format in Tables 3.4 to 3.6 is as follows:
• Row 1: life expectancy at birth
• Row 2: one-year survival ratios for newborns
• Row 3: one-year survival ratios for ages one to two
• Rows 4, 5, 6: one-year survival ratios for ages two to three, three to four, and four to
ﬁve.
• Row 7: the proportion of births during a ﬁve-year period that will survive within the
0-4 age group to the end of the period.
• Row 8: the proportion of those aged 0-4 who will survive into the 5-9 age group ﬁve
years later.
• Rows 9-23; the proportion of the age group (5-9, 10-14,· · · , 75-80) that will survive
into the next age group ﬁve years later.
• Row 24: the proportion of the age group 80+ that will survive ﬁve years later.
In the case of the WHO MLT, the survival ratios used in this study were computed from the
nLx column of Table 3.3 whereas for the other three MLTs the survival ratio values used in
the study were determined based on projected information about expectation of life at birth
done by the Malawi National Statistical Oﬃce. The projected life expectancy at birth values
for females for the period under consideration in this study are presented in Table 3.7. Since
the exact life expectancy at birth values presented in Table 3.7 are not available in Tables
3.4 to 3.6, linear interpolation was used to estimate the survival ratios corresponding to the
given life expectancy at birth values.
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Table 3.7: Projected life expectancy at birth values for females in Malawi
Year 1998 1999 2000 2001 2002 2003 2004
Life expectancy at birth 43.23 43.77 44.33 44.90 45.47 46.03 46.60
Source: http://www.nso.malawi.net/. Accessed on 15 August, 2007.
3.1.3 Estimating the number of HIV infected women
The number of women of a particular age, a, who are infected with HIV in year y, was
calculated using a formula similar to the one used in the mathematical model for making
HIV/AIDS projections which is implemented in a computer program called AIDS Impact
Model (AIM) (Stover, 2005). Below is the formula that was used for this task.
HIV
f ,a,y = Popf,a,y ×HIV_prevalencef ,a,y (3.16)
where, HIV
f ,a,y is the number of HIV infected women in age group a in year y, Popf,a,y is the
population of females aged a in year y obtained from equation 3.15 and HIV_prevalence
f ,a,y
is the estimated prevalence of HIV for females aged a in year y obtained in section 3.1.1.
3.1.4 Estimating the number of children
The methodology in the DemProj computer program was again adopted in calculating the
number of children born to all women in each year. For each year, the number of children
born to females in age group a was calculated as:
births
f ,a,y = Popf,a,y × ASFRf ,a,y (3.17)
where births
f ,a,y is the number of children born in year y to women of age a, Popf,a,y is
the population of females aged a in year y obtained from equation 3.15 and ASFR
f ,a,y
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is the age speciﬁc fertility rate (ASFR) in year y for women of age a. Here, since the
base year population we used was recorded in September we assume that Pop
f,a,y
would be
approximately equal to the mid-year population of females aged a in year y.
The ASFRs required in equation 3.17 were derived from the 2000 and 2004 Malawi DHSs
(NSO and ORC Macro, 2001 and 2005). We assumed a constant annual change in the ASFRs
between 2000 and 2004 and estimated the ASFRs for the years from 1999 to 2004 by linear
interpolation.
For each year, after calculating the number of children born to women in a particular age
group, the total number of children born to all women of reproductive age was calculated
using the formula:
birthsy =
45−49∑
a=15−19
births
f,a,y
(3.18)
3.1.5 Estimating the number of children infected with HIV through
mother-to-child transmission
We adopted the approach by UNAIDS/WHO in estimating the number of children acquiring
HIV infection from their mothers. For each year, we started by calculating the number of
children born to HIV infected women.
Two studies conducted in Uganda found that HIV-infected women had lower fertility rates
than HIV-negative women. One of the studies was done in rural Rakai district and found
that HIV infected women had ASFRs which were 55% less than those of non-HIV infected
women (Gray et al.,1998). The other study was conducted among rural women in Masaka and
found that the fertility rate in HIV-infected women was 26% lower than that of uninfected
women (Carpenter et al., 1997). On the basis of the ﬁndings from these studies it is assumed
that fertility might be 20 to 50 percent lower among HIV infected women compared to
uninfected women (The UNAIDS Reference Group on Estimates, Models and Projections,
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2003). However, The UNAIDS Reference Group on Estimates, Models and Projections
(2003) argues that fertility among young women who are HIV positive is likely to be higher
than that of all women since all HIV positive women are sexually active but not all young
women are sexually active. Therefore, in the UNAIDS/WHO approach it is assumed that
fertility among 15-19 year old women is 50% higher among HIV positive women than HIV
negative women and that fertility among women aged 20-49 is 20% lower among HIV positive
women than HIV negative women (The UNAIDS Reference Group on Estimates, Models and
Projections, 2003).
Let B+
f,a,y
denote the number of children born to HIV-positive women aged a years in year
y, B−f,a,y denote the number of children born to HIV-negative women aged a years in year
y and Neg
f,a,y
denote the mid-year population of HIV-negative women aged a years in year
y. Then using equations 3.15, 3.16 and 3.17 we have:
births
f ,a,y = B
+
f,a,y
+B−
f,a,y
(3.19)
Pop
f,a,y
= HIV
f ,a,y +Negf,a,y (3.20)
ASFR
f ,a,y =
B
f,a,y
Pop
f,a,y
=
B+
f,a,y
+B−
f,a,y
HIV
f ,a,y +Negf,a,y
(3.21)
From equation 3.21 we obtain
B+
f,a,y
+B−
f,a,y
= Pop
f,a,y
× ASFR
f ,a,y (3.22)
Dividing both sides of equation 3.22 by Neg
f,a,y
yields
B+
f,a,y
Neg
f,a,y
+
B−
f,a,y
Neg
f,a,y
=
Pop
f,a,y
Neg
f,a,y
× ASFR
f ,a,y (3.23)
Now assuming that fertility among 15-19 years old women is 50% higher among HIV-positive
than HIV-negative women we have
B+
f,a,y
HIV
f ,a,y
= 1.5× B
−
f,a,y
Neg
f,a,y
(3.24)
⇒ B
−
f,a,y
Neg
f,a,y
=
B+
f,a,y
1.5×HIV
f ,a,y
(3.25)
where a = 15− 19.
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Substituting equation 3.25 in equation 3.23 yields
B+
f,a,y
Neg
f,a,y
+
B+
f,a,y
1.5×HIV
f ,a,y
=
Pop
f,a,y
Neg
f,a,y
× ASFR
f ,a,y (3.26)
⇒ B
+
f,a,y
(1.5×HIV
f ,a,y +Negf,a,y)
1.5×HIV
f ,a,y ×Negf,a,y
=
Pop
f,a,y
Neg
f,a,y
× ASFR
f ,a,y (3.27)
⇒ B+
f,a,y
=
1.5×HIV
f ,a,y × Popf,a,y × ASFRf ,a,y
1.5×HIV
f ,a,y +Negf,a,y
(3.28)
Similarly, assuming that fertility among women 20-49 years old is 20% lower among HIV-
positive women than HIV-negative women we have
B+
f,a,y
HIV
f ,a,y
= 0.8× B
−
f,a,y
Neg
f,a,y
(3.29)
⇒ B
−
f,a,y
Neg
f,a,y
=
1.25×B+
f,a,y
HIV
f ,a,y
(3.30)
where a = {20− 24, ..., 44− 49}.
Substituting equation 3.30 in equation 3.23 gives
B+
f,a,y
Neg
f,a,y
+
1.25×B+
f,a,y
HIV
f ,a,y
=
Pop
f,a,y
Neg
f,a,y
× ASFR
f ,a,y (3.31)
⇒ B
+
f,a,y
(HIV
f ,a,y + 1.25×Negf,a,y)
HIV
f ,a,y ×Negf,a,y
=
Pop
f,a,y
Neg
f,a,y
× ASFR
f ,a,y (3.32)
⇒ B+
f,a,y
=
HIV
f ,a,y × Popf,a,y × ASFRf ,a,y
HIV
f ,a,y + 1.25×Negf,a,y
(3.33)
Combining the information in equations 3.28 and 3.33, the number of children born to HIV
infected mothers was computed using the formula:
HIV_births
f,a,y
=

1.5×HIV
f ,a,y
×Pop
f,a,y
×ASFR
f ,a,y
1.5×HIV
f ,a,y
+Neg
f,a,y
a = {15− 19}
HIV
f ,a,y
×Pop
f,a,y
×ASFR
f ,a,y
HIV
f ,a,y
+1.25×Neg
f,a,y
a = {20− 24, ..., 45− 49}
(3.34)
where HIV_births
f,a,y
denotes the number of children born to HIV-infected women aged a
in year y.
After calculating the number of children born to HIV infected women in each age group, the
formula
HIV_birthsy =
45−49∑
a=15−19
HIV_births
f,a,y
(3.35)
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was employed to calculate the total number of children born to all HIV infected women in a
given year y.
Finally, the number of children infected with HIV through MTCT in any given year was
calculated using the formula
HIV +_birthsy = HIV_birthsy × PTR (3.36)
where PTR denotes the perinatal transmission rate, which is deﬁned as the percentage of
children born to HIV-infected mothers who are infected themselves.
It has been documented that children acquire HIV infections from their mothers during
gestation or birth or after birth through breastfeeding (The UNAIDS Reference Group on
Estimates, Models and Projections, 2003). Based on a review of studies on MTCT, the
UNAIDS Reference Group on Estimates, Models and Projections reports that in developing
countries where a signiﬁcant amount of transmission may occur through breastfeeding, the
PTR lies between 25% and 48% in the absence of programs to prevent MTCT such as
treatment with nevirapine (NVP), or zidovudine (ZDV) and NVP, or some other treatment or
infant feeding options (The UNAIDS Reference Group on Estimates, Models and Projections,
2003; Stover, 2005). The UNAIDS/WHO approach is to use a value of 32% for the PTR
in SSA countries (The UNAIDS Reference Group on Estimates, Models and Projections,
2003; Stover, 2005). Other studies have used a rate of 30% (Adetunji, 2000) or 35% (Zaba
et al., 2003) for countries in SSA. In this study we used all the three proposed transmission
rates (i.e., 30%, 32% and 35%) inorder to generate alternative estimates of the number of
children infected with HIV via MTCT in the abscence of interventions to prevent MTCT.
Our assumption is that these three transmission rates are equally likely to arise in Malawi.
Beginning 2002, PMTCT services have been provided to a certain proportion of HIV infected
pregnant women in Malawi. According to the Malawi HIV and AIDS Monitoring and
Evaluation Report 2005, 2198 and 2719 HIV positive pregnant women received NVP in
2003 and 2004 respectively. We did not ﬁnd the exact number of HIV infected women that
received NVP in 2002. However, we assume it to be around 840, which is the number of
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pregnant women that tested positive in facilities providing PMTCT services (Ministry of
Health, Lighthouse Trust (Lilongwe) and CDC (Malawi), 2006). In our ﬁnal estimates of
the number of children infected with HIV via MTCT in Malawi we took into account the
HIV infected pregnant women that received NVP and used the default transmission rates
from AIM for women receiving NVP presented in Table 3.8 below.
Table 3.8: PTR for HIV infected pregnant women receiving Nevirapine.
Base transmission rate (no intervention) 30% 32% 35%
Transmission rate with intervention (NVP) 16% 24% 28%
Source: Spectrum software version 2.39.
http://www.unaids.org/en/HIV_data/Epidemiology/episoftware.asp.
Accessed on 15 August, 2007.
3.1.6 Estimating the number of HIV infected children dying before
the age of ﬁve years
It has been reported that children who are infected with HIV via MTCT generally progress
to AIDS faster than adults (The UNAIDS Reference Group on Estimates, Models and
Projections, 2003). The median time from birth to AIDS have been reported to range from
one year to 6.3 years based on a number of studies cited by The UNAIDS Reference Group
on Estimates, Models and Projections (2003). It has been reported that several of those
studies found that some children (about 40%) progress to AIDS within a few months while
the rest take considerably longer. A UNAIDS review of the available evidence suggests that
the survival of the infected children is best described by a rapid progression from infection to
death for some children and much slower progression for others (UNAIDS, 2001 cited by The
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UNAIDS Reference Group on Estimates, Models and Projections, 2003). On the basis of
this available evidence, The UNAIDS Reference Group on Estimates, Models and Projections
(2002) has developed procedures for estimating the proportion of children who are infected
with HIV via MTCT who will die from HIV-related causes y years after birth. This study
adopted those procedures to estimate the number of children dying due to HIV/AIDS before
their ﬁfth birthday in Malawi during the period 2000 to 2004.
According to The UNAIDS Reference Group on Estimates, Models and Projections'
procedures, the shape of the survival curve for HIV-infected children up to the age of 15
is speciﬁed by the following double Weibull function:
S(y) = 1− [p(1− exp(−(β1y)α1)) + (1− p)(1− exp(−(β2y)α2))] (3.37)
where S(y) represents the fraction of children who have not died from HIV-related causes y
years after birth, p is the proportion of children who progress to death rapidly, α1, β1, α2 and
β2, are parameters of the component Weibull curves describing mortality amongst the group
of children that progress to death rapidly and the group of children that progress to death
slowly respectively (Zaba et al., 2003). An analysis conducted by The UNAIDS Reference
Group on Estimates Models and Projections (2002) found that the parameter values that
gave the best ﬁt to a wide range of net survival data measured in clinic and community
based cohorts were p = 0.6, α1 = 0.9, β1 = 0.9, α2 = 10.0 and β2 = 0.1. These parameter
values are the ones that were used in this study in estimating the number of HIV-infected
children who would die before the age of ﬁve years in Malawi during the period in question.
Figure 3.1 shows the curve of the cumulative proportion of the HIV-infected children that
progress to AIDS death y years after birth using the stated parameters. The curve indicates
that over a third of infected children would die before their ﬁrst birthday, nearly two thirds
by age ﬁve and none of them would survive past the age of 15.
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Figure 3.1: Survival distribution of HIV-infected children.
Source: The UNAIDS Reference Group on Estimates Models and Projections (2002).
3.1.7 Estimating the proportion of under-ﬁve mortality in Malawi
during the period 2000 to 2004 that is directly attributable
to HIV/AIDS
We adopted the approach by Walker et al. (2002) to move from the estimates of the total
number of HIV infected children dying before the age of ﬁve years during the period 2000
to 2004 computed by the procedures described above to estimates of the proportion of
under-ﬁve mortality directly attributable to HIV/AIDS in Malawi from 2000 to 2004. First,
we computed estimates of U5MR in HIV-infected children by dividing the estimated total
number of HIV infected children dying before the age of ﬁve years from 2000 to 2004 by
the estimated total number of children infected with HIV through MTCT from 2000 to
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2004. Second, we computed estimates of U5MR for HIV-negative children by subtracting the
estimates of U5MR in HIV-infected children from the 2004 Malawi DHS estimate of U5MR
from all causes. Third, we used the computed estimates of U5MR without HIV/AIDS to
compute estimates of the total number of HIV infected children dying before the age of ﬁve
years from non-HIV causes from 2000 to 2004 since HIV infected children can also die from
non-HIV related causes (Walker et al., 2002). Fourth, we subtracted estimates of the total
number of HIV infected children dying before the age of ﬁve years from non-HIV causes
from 2000 to 2004 from the estimates of total number of HIV infected children dying before
the age of ﬁve years from 2000 to 2004 to obtain estimates of the total number of HIV
infected children dying before the age of ﬁve years from HIV related causes from 2000 to
2004. Fifth, we computed estimates of U5MR due to HIV/AIDS from 2000 to 2004 by
dividing the estimates of the total number of HIV infected children dying before the age
of ﬁve years from HIV related causes from 2000 to 2004 by the estimated total number
of children born to all women from 2000 to 2004. Lastly, we computed estimates of the
proportion of U5MR attributable to HIV/AIDS in Malawi during the period 2000 to 2004
by dividing the estimates of U5MR due to HIV/AIDS from 2000 to 2004 by the 2004 Malawi
DHS estimates of U5MR.
3.2 Data sources
The study mainly used secondary data collected by government departments and other
institutions working on HIV/AIDS related issues in Malawi as well as data from relevant
published studies and reports. Below we present the sources of data which formed the basis
of the HIV/AIDS and demographic estimates and projections done in this study.
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3.2.1 HIV prevalence data
Until recently, the most widely available source of epidemiological data on HIV prevalence
in Malawi has been a routine ANC surveillance system. Since 1994, 19 sentinel ANC sites
located in the urban and the rural areas in all the three regions (North, Central, and South)
have been used to collect data on HIV prevalence every one or two years using consistent
methodology in the same population group (MEASURE Evaluation, 2004; NSO and Macro
International Inc., 2005). Therefore, data for setting assumptions about the prevalence of
HIV among women in each age group from age 15 to age 49 from 1999 to 2005 were obtained
from the Epidemiology Department of the Malawi Ministry of Health and Population.
3.2.2 Demographic data
The 1998 Malawi Population and Housing Census Analytic Report (NSO, 2002) was the
source of the base year population for estimating the number of women of reproductive age
for each year from 1999 to 2004. Information on ASFRs was obtained from the 2000 and
2004 Malawi DHSs.
3.3 Software
Most of the computations needed in this study were done using R version 2.4.1. R is a freely
available language and environment for statistical computing and graphics which provides
a wide variety of statistical and graphical techniques: linear and nonlinear modelling,
statistical tests, time series analysis, classiﬁcation, clustering, and many more others.
More information about R and instruction for downloading a copy is available on the R
home page (http://www.r-project.org). Analysis of the HIV prevalence data was done
using SPSS version 14. This thesis document was typeset in LATEX using MiKTeX 2.5
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installation downloaded from http://sourceforge.net/projects/miktex/ and TeXnicCenter
editor downloaded from http://sourceforge.net/projects/texniccenter/.
51
Chapter 4
Results
This chapter presents estimates of the proportion of under-ﬁve mortality directly attributed
to HIV/AIDS in Malawi. First, the chapter presents estimates of HIV prevalence among
women of reproductive age from 1999 to 2005. Second, it presents estimates of the number
of women of reproductive age in Malawi from 1999 to 2004. In the third part the chapter
presents estimates of the number of women of reproductive age infected with HIV. The fourth
and ﬁfth parts present estimates of the number of children born to all women and estimates
of the number of children infected with HIV through MTCT respectively. The sixth part
presents estimates of the number of HIV infected children dying before the age of ﬁve years.
At the end, the chapter presents estimates of the proportion of under-ﬁve mortality directly
attributed to HIV/AIDS in Malawi during the period 2000 to 2004.
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4.1 Estimates of HIV prevalence among women of
reproductive age
In this section we present estimates of HIV prevalence among women of reproductive age in
Malawi from 1999 to 2005. We present ANC sentinel surveillance results ﬁrst and end the
section with ﬁnal estimates of HIV prevalence among women of reproductive age in Malawi.
4.1.1 ANC sentinel surveillance sites in Malawi, 1999 to 2005
Since 1999, ANC HIV surveillance in Malawi has been conducted every two years in 19 sites
in all the three regions of the country shown in Figure 4.1. Eight of the sites are classiﬁed
as rural clinics, Eight as semi-urban clinics and three as urban clinics (see Table 4.1). As
stated earlier, in this study we reclassiﬁed the ANC sentinel sites into urban and non-urban
sites. Based on our classiﬁcation of the sentinel sites, the numbers of women sampled in the
ANC surveillance surveys by site category in Malawi from 1999 to 2005 are shown in Table
4.2. Although Table 4.2 shows that the total numbers of women sampled in non-urban sites
were consistently more than the total numbers of women sampled in urban sites, the women
sampled in the former were predominantly from semi-urban sites. For instance in 2003 the
69.2% of women sampled in the non-urban sites comprised 48.9% of women from semi-urban
sites.
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Figure 4.1: ANC sentinel surveillance sites in Malawi, 1999 to 2005
Source: NAC (2003b)
Note: Limbe Health Centre and Mzuzu Health Centre replaced Queen Elizabeth Central
Hospital and St. John's Mission Hospital respectively which were used in 1999 and 2001.
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Table 4.1: Classiﬁcation of ANC sentinel surveillance sites in Malawi, 1999 to 2005.
Sentinel site Region Category
Kaporo Health Centre North Rural
Mbalachanda Health centre North Rural
Rumphi District Hospital North Semi-urban
Nkhata-Bay District Hospital North Semi-urban
Mzuzu Health Centre North Urban
Kamboni Health Centre Centre Rural
Thonje Health Centre Centre Rural
Kasina Health Centre Centre Rural
Mchinji District Hospital Centre Semi-urban
St. Anne's Mission Hospital Centre Semi-urban
Ntcheu District Hospital Centre Semi-urban
Lilongwe Central Hospital Centre Urban
Gawanani Health Centre South Rural
Milepa Health Centre South Rural
Mianga Health Centre South Rural
Mangochi District Hospital South Semi-urban
Mulanje Mission Hospital South Semi-urban
Nsanje District Hospital South Semi-urban
Limbe Health Centre South Urban
Source: NAC (2003c)
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Table 4.2: Trends in the number of women sampled in ANC sentinel surveillance surveys in
Malawi from 1999 to 2005 by site category.
Sentinel site 1999 2001 2003 2005
category Number % Number % Number % Number %
Urban 1 901 27.6 1 853 25.1 2 460 30.8 2 564 28.6
Non-urban 4 984 72.4 5 521 74.9 5 517 69.2 6 390 71.4
Total 6 885 100 7 374 100 7 977 100 8 954 100
4.1.2 Age patterns of women sampled in ANC surveillance surveys
in Malawi, 1999 to 2005
As evident in Table 4.3, the age pattern of women recruited in all the surveys in urban and
non-urban sites from 1999 to 2005 was very similar. In both urban and non-urban sites, the
samples comprised of relatively young women in their prime years of sexual activity. Women
aged less than 30 years constituted over 75% of the samples in both categories with at least
55% of the women being aged between 15 and 24 years.
4.1.3 Age speciﬁc HIV prevalence among women sampled in ANC
sentinel surveillance surveys
Age speciﬁc HIV prevalence among women aged 15-49 sampled in ANC surveillance surveys
in Malawi from 1999 to 2005 for aggregated urban and non-urban sites are presented in
Tables 4.4 and 4.5 respectively. As can be noted from these tables, HIV prevalence remained
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Table 4.3: Age patterns of women sampled in ANC surveillance surveys in Malawi, 1999 to
2005.
Panel A:Urban Sites
1999 2001 2003 2005
Age group Number % Number % Number % Number %
<15 4 0.2 5 0.3 2 0.1 8 0.8
15-19 378 19.9 354 19.2 481 19.6 487 19.1
20-24 816 43.1 781 42.5 1079 44.1 1057 41.5
25-29 420 22.2 440 23.9 565 23.1 628 24.7
30-34 191 10.1 190 10.3 251 10.3 279 11.0
35-39 76 4.0 62 3.4 60 2.5 72 2.8
40-49 9 0.5 7 0.4 9 0.4 14 0.5
50+ 1 0.1 - - 1 0.0 1 0.0
Total 1895 100 1839 100 2448 100 2546 100
Panel B:Non-urban Sites
1999 2001 2003 2005
Age group Number % Number % Number % Number %
<15 8 0.2 13 0.2 13 0.2 5 0.1
15-19 1 153 23.5 1 203 22.1 1 133 20.7 1 294 20.4
20-24 1 913 39.0 1 977 36.3 2 124 38.8 2 324 36.6
25-29 990 20.2 1 204 22.1 1 157 21.1 1 408 22.2
30-34 499 10.2 647 11.9 641 11.7 854 13.4
35-39 258 5.3 313 5.7 319 5.8 326 5.1
40-49 84 1.7 92 1.7 84 1.5 134 2.1
50+ 2 0.0 2 0.0 7 0.1 10 0.2
Total 4 907 100 5 451 100 5 478 100 6 355 100
above 10% across all age groups in both aggregated urban and non-urban sites during the
entire period from 1999 to 2005. The conﬁdence intervals in these tables suggest that HIV
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prevalence in the youngest women (15-19 age group) remained signiﬁcantly lower than that
in the older women throughout the period 1999 to 2005. Furthermore, for both aggregated
urban and non-urban sites, HIV prevalence ﬁgures peaked in the 25-29 and 30-34 age groups
throughout the period 1999 to 2005 as the conﬁdence intervals for HIV prevalence ﬁgures in
the two age groups indicate no statistical signiﬁcant diﬀerences.
Table 4.4: Age speciﬁc HIV prevalence for women sampled in ANC surveillance surveys in
aggregated urban sites in Malawi, 1999 to 2005.
1999 2001
Age Total Number % 95% Total Number % 95%
group sampled HIV+ HIV+ CI sampled HIV+ HIV+ CI
15-19 378 77 20.4 16.6-24.7 354 41 11.6 8.6-15.4
20-24 816 203 24.9 22.0-27.9 781 187 23.9 21.1-27.1
25-29 420 118 28.1 24.0-32.6 440 118 26.8 22.9-31.2
30-34 191 59 30.9 24.8-37.8 190 48 25.3 19.6-31.9
35-39 76 22 28.9 19.9-40.1 62 18 29.0 19.2-41.4
40-49 9 2 22.2 5.3-55.7 7 1 14.3 1.14-58.23
2003 2005
Age Total Number % 95% Total Number % 95%
group sampled HIV+ HIV+ CI sampled HIV+ HIV+ CI
15-19 481 78 16.2 13.2-19.8 487 62 12.7 10.1-16.0
20-24 1 079 225 20.9 18.5-23.4 1 057 198 18.7 16.5-21.2
25-29 565 138 24.4 21.1-28.1 628 156 24.8 21.6-28.4
30-34 251 75 29.9 24.5-35.8 279 82 29.4 24.3-35.0
35-39 60 12 20.0 11.7-31.9 72 17 23.6 15.2-34.7
40-49 9 3 33.3 11.7-64.9 14 1 7.1 <0.001-33.5
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Table 4.5: Age speciﬁc HIV prevalence for women sampled in ANC surveillance surveys in
aggregated non-urban sites in Malawi, 1999 to 2005.
1999 2001
Age Total Number % 95% Total Number % 95%
group sampled HIV+ HIV+ CI sampled HIV+ HIV+ CI
15-19 1 153 210 18.2 16.1-20.6 1 203 141 11.7 10.0-13.7
20-24 1 913 495 25.9 24.0-27.9 1 977 370 18.7 17.1-20.5
25-29 990 281 28.4 25.7-31.3 1 204 287 23.8 20.8-25.6
30-34 499 113 22.6 19.2-26.5 647 137 21.2 18.2-24.5
35-39 258 47 18.2 14.0-23.4 313 59 18.8 14.9-23.6
40-49 84 13 15.5 9.1-24.8 92 12 13.0 7.5-21.6
2003 2005
Age Total Number % 95% Total Number % 95%
group sampled HIV+ HIV+ CI sampled HIV+ HIV+ CI
15-19 1 133 167 14.7 12.8-16.9 1 294 121 9.4 7.9-11.1
20-24 2 124 410 19.3 17.7-21.0 2 324 356 15.3 13.9-16.8
25-29 1 157 246 21.3 19.0-23.7 1 408 283 20.1 18.1-22.3
30-34 641 144 22.5 19.4-25.9 854 151 17.7 15.3-20.4
35-39 319 53 16.6 12.9-21.1 326 53 16.3 12.6-20.7
40-49 84 16 19.0 12.0-28.8 134 21 15.7 10.4-22.8
An examination of trends in the age speciﬁc HIV prevalence among the women sampled
in ANC surveillance surveys in Malawi during the period 1999 to 2005 indicated that HIV
prevalence in younger age groups declined but remained almost stable in old women. As
depicted in Figures 4.2 and 4.3 there was a general downward trend in HIV prevalence
between 1999 and 2005 in the 15-19, 20-24 and 25-29 age groups in both the aggregated
urban and non-urban sites. However, in both sentinel site categories the decline was more
pronounced in the 15-19 and 20-24 age groups. As Table 4.4 shows, the numbers of women
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aged 40-49 sampled in the ANC surveillance surveys in the urban sites were very small,
therefore the trends in HIV prevalence in this age group should be interpreted with caution.
The trendline of HIV prevalence for women aged 40-49 in urban sites shown in Figure 4.2
might not be a true representation of reality. Thus, the peak shown in Figure 4.2 does not
necessarily mean HIV prevalence in urban areas in Malawi was highest among women aged
40-49 compared to women in the younger age groups in 2003.
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Figure 4.2: Age speciﬁc HIV prevalence in aggregated urban sites.
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Figure 4.3: Age speciﬁc HIV prevalence in aggregated non-urban sites.
4.1.4 Adjusted age speciﬁc HIV prevalence for non-urban sites
Because the sites we classiﬁed as non-urban are located in small towns and large rural
settlements with higher levels of economic activity and mobility and probably associated
with higher HIV prevalence and may therefore over-estimate HIV prevalence in most remote
areas, consistent with the UNAIDS/WHO approach, we adjusted down the age speciﬁc HIV
prevalence ﬁgures in non-urban sites presented in Table 4.5 by 20%. The adjusted age speciﬁc
HIV prevalence ﬁgures for the aggregated non-urban sites are presented in Table 4.6.
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Table 4.6: Age speciﬁc HIV prevalence for aggregated non-urban sites in Malawi from 1999
to 2005 adjusted for representativeness.
HIV prevalence (%)
Age group 1999 2001 2003 2005
15-19 14.6 9.4 11.8 7.5
20-24 20.7 15.0 15.4 12.2
25-29 22.7 19.0 17.0 16.1
30-34 18.1 17.0 18.0 14.2
35-39 14.6 15.0 13.3 13.0
40-49 12.4 10.4 15.2 12.6
4.1.5 National estimates of age speciﬁc HIV prevalence among
women based on ANC surveillance data
Applying the estimates of the percentages of female populations in urban and rural areas to
the estimates of age speciﬁc HIV prevalence for the aggregated urban and non-urban sites
presented in Tables 4.4 and 4.6 respectively, yielded preliminary estimates of national age-
speciﬁc HIV prevalence for women in Malawi from 1999 to 2005 based on ANC surveillance
data presented in Table 4.7.
Estimates of national age speciﬁc HIV prevalence among women based on the ANC
surveillance data for the years 2000, 2002 and 2004 were linearly interpolated from the
HIV prevalence ﬁgures presented in Table 4.7. The interpolated estimates of age speciﬁc
HIV prevalence together with the age speciﬁc HIV prevalence ﬁgures in Table 4.7 formed
the ﬁnal national estimates of age speciﬁc HIV prevalence among women based on ANC
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Table 4.7: Preliminary estimates of the national age speciﬁc HIV prevalence among women
in Malawi from 1999 to 2005 based on ANC surveillance data.
HIV prevalence (%)
Age group 1999 2001 2003 2005
15-19 15.5 9.8 12.6 8.5
20-24 21.5 16.7 16.5 13.6
25-29 23.6 20.4 18.4 17.8
30-34 20.0 18.3 20.0 16.8
35-39 16.5 17.0 14.3 14.7
40-49 13.4 10.8 17.3 11.9
surveillance data presented in Table 4.8.
Table 4.8: Final estimates of the national age speciﬁc HIV prevalence among women in
Malawi from 1999 to 2004 based on ANC surveillance data
HIV prevalence (%)
Age group 1999 2000 2001 2002 2003 2004 2005
15-19 15.5 12.6 9.8 11.2 12.6 10.6 8.5
20-24 21.5 19.1 16.7 16.6 16.5 15.1 13.6
25-29 23.6 22.0 20.4 19.4 18.4 18.1 17.8
30-34 20.0 19.2 18.3 19.1 20.0 18.4 16.8
35-39 16.5 16.8 17.0 15.7 14.3 14.5 14.7
40-49 13.4 12.1 10.8 14.1 17.3 14.6 11.9
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As depicted in Figure 4.4, the ﬁnal estimates of national age speciﬁc HIV prevalence among
women in Malawi from 1999 to 2005 based on the ANC surveillance data suggest that the
trajectory of HIV prevalence across age groups was almost similar in all the years except
2003. With the exception of the 40-49 age group whose prevalence ﬁgures were aﬀected
by small sample sizes as indicated earlier, HIV prevalence rates were lowest among women
aged 15-19 years and peaked among women aged 25-29 years. Figure 4.4 also reveals that
there was a substantial decline in national HIV prevalence among women in the younger age
groups (15-19, 20-24 and 25-29).
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Figure 4.4: National estimates of age speciﬁc HIV prevalence among women based on ANC
data.
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4.1.6 Final national estimates of age speciﬁc HIV prevalence among
women based on ANC surveillance data and 2004 Malawi
DHS results
For the ﬁrst time Malawi has national population-based HIV prevalence estimates for women
and men derived from the 2004 Malawi DHS which included HIV testing. The age speciﬁc
national HIV prevalence estimates for women of reproductive age derived from the 2004
Malawi DHS are presented in Table 4.9.
Table 4.9: Estimates of age speciﬁc HIV prevalence among females aged 15-49 in Malawi
derived from 2004 Malawi DHS
Age group Number tested HIV prevalence (%)
15-19 500 3.7
20-24 661 13.2
25-29 477 15.5
30-34 382 18.1
35-39 257 17.0
40-49 408 15.9
Source: NSO and ORC Macro (2005).
Note: Numbers for the 40-49 age group were computed by author based on the original
numbers in the 40-44 and 45-49 age groups in the 2004 Malawi DHS report.
A comparison was made between the national estimates of age speciﬁc HIV prevalence among
females aged 15-49 in Malawi for the year 2004 derived from the 2004 Malawi DHS and
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those based on the ANC surveillance data. According to NSO and ORC Macro (2005), the
2004 Malawi DHS was conducted from October 2004 to January 2005 while the 2005 ANC
surveillance was conducted over a period of eight weeks starting on 1 August 2005 (NAC
2005). Therefore, appropriate HIV prevalence estimates from the ANC surveillance data that
could be compared to the HIV prevalence estimates derived from the 2004 Malawi DHS were
computed as the average of the estimates of HIV prevalence based on ANC surveillance data
for the years 2004 and 2005 presented in Table 4.8. Figure 4.5 illustrates the comparison
analysis of the computed HIV prevalence estimates from the ANC surveillance data and
the HIV prevalence estimates from the 2004 Malawi DHS. As can be noted from Figure 4.5,
estimates of HIV prevalence by age based on the ANC surveillance data diﬀer from estimates
of HIV prevalence for the general population derived from the 2004 Malawi DHS. For the 15-
19, 20-24 and 25-29 age groups, estimates of HIV prevalence based on the ANC surveillance
data are higher than those obtained from the 2004 Malawi DHS and there is a reversed
relationship when comparing the 30-34, 35-39 and 40-49 age groups. This cross-over eﬀect,
although with diﬀerent magnitudes, has been observed in most studies comparing estimates
of HIV prevalence from ANC surveillance data and HIV prevalence in the general population
(Fylkesnes et al., 1998; WHO and UNAIDS 2003). For this study, the magnitudes of the
diﬀerences between the estimates of HIV prevalence by age based on ANC surveillance data
and those derived from the 2004 Malawi DHS are presented in Table 4.10 as ratios of ANC
HIV prevalence to general population HIV prevalence.
The estimates of age speciﬁc ratios of ANC HIV prevalence to general population HIV
prevalence presented in Table 4.10 were used to further adjust the estimates of HIV
prevalence by age based on ANC surveillance data presented in Table 4.8 to obtain ﬁnal
estimates of national HIV prevalence by age for all women of reproductive age in Malawi for
the years 1999 to 2005. This yielded estimates of national HIV prevalence by age for women
of reproductive age in Malawi for the years 1999 to 2005 presented in Table 4.11.
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Figure 4.5: Comparison between estimates of age speciﬁc HIV prevalence among women
aged 15-49 in Malawi in 2004 based on 2004 Malawi DHS and ANC data.
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Table 4.10: Estimates of ratios of ANC HIV prevalence to general population HIV prevalence
Age group Ratio of ANC HIV prevalence to general population HIV prevalence
15-19 2.58
20-24 1.09
25-29 1.16
30-34 0.97
35-39 0.86
40-49 0.83
Table 4.11: Final estimates of age speciﬁc national HIV prevalence among women of
reproductive age in Malawi, 1999 to 2005
HIV Prevalence (%)
Age group 1999 2000 2001 2002 2003 2004 2005
15-19 6.0 4.9 3.8 4.3 4.9 4.1 3.3
20-24 19.8 17.6 15.4 15.3 15.2 13.9 12.5
25-29 20.4 19.0 17.7 16.8 15.9 15.6 15.4
30-34 20.6 19.7 18.8 19.7 20.5 18.9 17.3
35-39 19.2 19.5 19.8 18.2 16.6 16.9 17.1
40-49 16.2 14.6 13.0 16.9 20.8 17.6 14.3
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4.2 Estimates of women of reproductive age
Four diﬀerent sets of estimates of women of reproductive age in Malawi for the period 1999
to 2004 were made. The estimates were obtained by projecting the age smoothed population
of females presented in Table 4.12 which was obtained from the analytic report of the 1998
census (NSO, 2002) using four diﬀerent MLT systems as outlined in the methodology section
(section 3.1.2). The ﬁrst set of estimates was done using survival ratios derived from the
WHOMLT system, the second using survival ratios derived from the United Nations Far East
MLT system, the third using survival ratios derived from the north family of Coale-Demeny
MLT system and the fourth using survival ratios derived from the south family of Coale-
Demeny MLT system. Tables 4.13 to 4.20 present the estimates of women of reproductive
age in Malawi for the years 1999 to 2004 based on these four MLT systems.
Table 4.12: Age smoothed population of females in Malawi in 1998.
Age group Population size Age group Population size
0-4 835 780 40-44 193 647
5-9 726 525 45-49 153 393
10-14 623 625 50-54 112 069
15-19 552 501 55-59 91 901
20-24 514 183 60-64 80 856
25-29 428 291 65-69 73 642
30-34 304 987 70-74 69 004
35-39 238 958 75 & over 66 943
Source: NSO, 2002.
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Table 4.13: Estimates of women of reproductive age in Malawi from 1999 to 2001 based on
WHO MLT system.
1999 2000 2001
Age Population % of Population % of Population % of
group size total size total size total
15-19 560 239 23.06 570 221 23.05 582 307 23.11
20-24 517 703 21.31 519 534 21.00 520 961 20.68
25-29 440 324 18.12 450 606 18.21 459 068 18.22
30-34 317 056 13.05 331 614 13.40 347 113 13.78
35-39 241 113 9.92 243 394 9.84 246 608 9.79
40-44 195 764 8.06 197 740 7.99 199 623 7.92
45-49 157 459 6.48 160 807 6.50 163 545 6.49
Total 2 429 658 100.00 2 473 916 100.00 2 519 225 100.00
Table 4.14: Estimates of women of reproductive age in Malawi from 2002 to 2004 based on
WHO MLT system.
2002 2003 2004
Age Population % of Population % of Population % of
group size total size total size total
15-19 596 143 23.23 611 441 23.38 627 702 23.54
20-24 523 636 20.41 528 742 20.22 536 189 20.11
25-29 465 737 18.15 470 768 18.00 473 939 17.77
30-34 361 661 14.09 374 011 14.30 384 478 14.42
35-39 251 714 9.81 259 146 9.91 269 409 10.10
40-44 201 451 7.85 203 304 7.77 205 138 7.69
45-49 165 842 6.46 167 838 6.42 169 676 6.36
Total 2 566 184 100.00 2 615 250 100.00 2 666 531 100.00
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Table 4.15: Estimates of women of reproductive age in Malawi from 1999 to 2001 based on
UN Far East MLT system.
1999 2000 2001
Age Population % of Population % of Population % of
group size total size total size total
15-19 558 298 22.84 566 582 22.63 577 195 22.51
20-24 517 928 21.19 519 635 20.76 520 586 20.30
25-29 444 097 18.17 457 705 18.29 468 995 18.29
30-34 322 037 13.18 341 768 13.65 362 691 14.14
35-39 245 240 10.03 251 911 10.06 259 845 10.13
40-44 198 283 8.11 203 167 8.12 208 360 8.13
45-49 158 026 6.47 162 384 6.49 166 582 6.50
Total 2 443 909 100.00 2 503 152 100.00 2 564 254 100.00
Table 4.16: Estimates of women of reproductive age in Malawi from 2002 to 2004 based on
UN Far East MLT system.
2002 2003 2004
Age Population % of Population % of Population % of
group size total size total size total
15-19 589 768 22.44 603 972 22.42 619 517 22.42
20-24 522 421 19.88 526 281 19.53 532 715 19.28
25-29 477 963 18.19 484 708 17.99 489 191 17.70
30-34 382 848 14.57 400 830 14.88 416 470 15.07
35-39 270 145 10.28 283 403 10.52 299 870 10.85
40-44 213 916 8.14 219 924 8.16 226 157 8.18
45-49 170 796 6.50 175 167 6.50 179 730 6.50
Total 2 627 857 100.00 2 694 285 100.00 2 763 650 100.00
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Table 4.17: Estimates of women of reproductive age in Malawi from 1999 to 2001 based on
Coale-Demeny north MLT system.
1999 2000 2001
Age Population % of Population % of Population % of
group size total size total size total
15-19 559 574 22.79 568 674 22.52 579 654 22.33
20-24 520 125 21.19 523 769 20.75 526 384 20.28
25-29 446 241 18.18 461 991 18.30 475 373 18.31
30-34 323 622 13.18 345 064 13.67 367 820 14.17
35-39 246 492 10.04 254 431 10.08 263 659 10.16
40-44 199 529 8.13 205 632 8.14 212 018 8.17
45-49 159 441 6.49 165 173 6.54 170 693 6.58
Total 2 455 024 100.00 2 524 734 100.00 2 595 601 100.00
Table 4.18: Estimates of women of reproductive age in Malawi from 2002 to 2004 based on
Coale-Demeny north MLT system.
2002 2003 2004
Age Population % of Population % of Population % of
group size total size total size total
15-19 592 147 22.19 605 843 22.09 620 473 22.00
20-24 529 624 19.85 534 683 19.49 541 907 19.22
25-29 486 339 18.23 494 975 18.05 501 087 17.77
30-34 389 897 14.61 409 840 14.94 427 409 15.16
35-39 275 309 10.32 290 014 10.57 308 071 10.93
40-44 218 739 8.20 225 887 8.24 233 274 8.27
45-49 176 170 6.60 181 744 6.63 187 488 6.65
Total 2 668 225 100.00 2 742 986 100.00 2 819 709 100.00
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Table 4.19: Estimates of women of reproductive age in Malawi from 1999 to 2001 based on
Coale-Demeny South MLT system.
1999 2000 2001
Age Population % of Population % of Population % of
group size total size total size total
15-19 559 888 22.78 569 420 22.50 580 951 22.30
20-24 520 317 21.17 524 165 20.71 526 996 20.23
25-29 446 653 18.17 462 778 18.28 476 491 18.29
30-34 324 190 13.19 346 203 13.68 369 535 14.18
35-39 247 101 10.05 255 644 10.10 265 476 10.19
40-44 200 099 8.14 206 784 8.17 213 762 8.20
45-49 159 899 6.50 166 115 6.56 172 142 6.61
Total 2 458 147 100.00 2 531 109 100.00 2 605 353 100.00
Table 4.20: Estimates of women of reproductive age in Malawi from 2002 to 2004 based on
Coale-Demeny South MLT system.
2002 2003 2004
Age Population % of Population % of Population % of
group size total size total size total
15-19 594 122 22.16 608 629 22.05 624 296 21.98
20-24 530 465 19.78 535 775 19.41 543 373 19.13
25-29 487 736 18.19 496 603 17.99 502 962 17.71
30-34 392 181 14.63 412 671 14.95 430 749 15.16
35-39 277 745 10.36 293 107 10.62 311 850 10.98
40-44 221 088 8.24 228 861 8.29 236 873 8.34
45-49 178 150 6.64 184 282 6.68 190 597 6.71
Total 2 681 487 100.00 2 759 928 100.00 2 840 700 100.00
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4.2.1 Comparison of estimates of women of reproductive age in
Malawi from 1999 to 2004
As can be noted from Tables 4.13 to 4.20, throughout the years the estimates based on
all the four MLT systems indicate that about 75% of the women in the 15-49 age group
in Malawi were less than 35 years old. Furthermore, as shown in Figure 4.6, the WHO
MLT system produced the lowest estimates of the total population of women aged 15-49 in
Malawi from 1999 to 2004 and the highest estimates were obtained from the south family
of Coale-Demeny MLT system. In addition, comparison between the four sets of estimates
of the total population of women aged 15-49 in Malawi from 1999 to 2004 derived from
the four MLT systems and estimates done by the Malawi National Statistical Oﬃce and
the National AIDS Commission revealed that there were no huge diﬀerences between the
estimates derived from the north family of Coale-Demeny MLT system and those done by
the National AIDS Commission (see Figure 4.7). Figure 4.7 further indicates that there were
also no huge diﬀerences between estimates derived from the south family of Coale-Demeny
MLT system and those done by the Malawi National Statistical Oﬃce.
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Figure 4.6: Comparison of estimates of total women population aged 15-49 in Malawi from
1999 to 2004.
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Figure 4.7: Comparison of estimates of women aged 15-49 in Malawi from 1999-2004
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4.3 Estimates of the number of HIV infected women
Estimates of the number of women aged 15-49 infected with HIV were made by applying
the age speciﬁc estimates of HIV prevalence presented in Table 4.11 to the estimates of the
total population of women aged 15-49 in Malawi presented in Tables 4.13 to 4.20. A range
of the obtained estimates are presented in Tables 4.21 to 4.24. Interestingly, the estimates
of the number of women aged 15-49 infected with HIV presented in Tables 4.21 to 4.24
yield estimates of HIV prevalence for adult females (age 15-49) in Malawi for the years 2000
to 2004 that diverge only very narrowly from those presented in Table 4.25, which were
produced by NAC (2005) using the Spectrum package in combination with the Estimation
and Projection Package. The diﬀerences between the estimates of HIV prevalence for adult
females in Malawi from 2000 to 2004 obtained in this study and NAC (2005)'s estimates
range from 0.6 to 2.1 percentage points with the estimates obtained in this study being
lower than NAC (2005)'s estimates in all the years as shown in Figure 4.8.
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Table 4.21: Estimates of the number of HIV infected women in Malawi for estimates of
women based on WHO MLT system.
Age group 1999 2000 2001 2002 2003 2004
15-19 33 734 27 947 22 016 25 809 29 826 25 690
20-24 102 470 91 304 79 994 80 085 80 544 74 411
25-29 89 973 85 814 81 049 78 173 74 919 74 115
30-34 65 264 65 294 65 241 71 130 76 823 72 718
35-39 46 342 47 530 48 918 45 910 43 126 45 478
40-44 31 619 28 848 26 004 34 081 42 307 36 017
45-49 25 432 23 460 21 304 28 057 34 927 29 791
Total HIV-infected
women (15-49) 394 834 370 197 344 526 363 245 382 472 358 220
% HIV-infected
women (15-49) 16.3 15.0 13.7 14.2 14.6 13.4
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Table 4.22: Estimates of the number of HIV infected women in Malawi for estimates of
women based on UN Far East MLT system.
Age group 1999 2000 2001 2002 2003 2004
15-19 33 618 27 769 21 823 25 533 29 462 25 355
20-24 102 515 91 322 79 936 79 899 80 169 73 929
25-29 90 743 87 166 82 802 80 225 77 138 76 500
30-34 66 289 67 293 68 169 75 298 82 331 78 769
35-39 47 135 49 194 51 544 49 272 47 163 50 620
40-44 32 026 29 640 27 142 36 190 45 765 39 707
45-49 25 524 23 690 21 700 28 895 36 452 31 556
Total HIV-infected
women (15-49) 397 850 376 074 353 116 375 312 398 480 376 436
% HIV-infected
women (15-49) 16.3 15.0 13.8 14.3 14.8 13.6
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Table 4.23: Estimates of the number of HIV infected women in Malawi for estimates of
women based on Coale-Demeny North MLT system.
Age Group 1999 2000 2001 2002 2003 2004
15-19 33 694 27 871 21 916 25 636 29 553 25 394
20-24 102 950 92 048 80 827 81 001 81 449 75 204
25-29 91 182 87 983 83 928 81 631 78 772 78 360
30-34 66 615 67 942 69 133 76 684 84 182 80 838
35-39 47 376 49 686 52 300 50 214 48 263 52 004
40-44 32 227 30 000 27 618 37 006 47 006 40 957
45-49 25 752 24 097 22 235 29 804 37 820 32 918
Total HIV infected
women (15-49) 399 796 379 627 357 957 381 976 407 045 385 675
% HIV-infected
women (15-49) 16.3 15.0 13.8 14.3 14.8 13.7
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Table 4.24: Estimates of the number of HIV infected women in Malawi for estimates of
women based on Coale-Demeny South MLT system.
Age Group 1999 2000 2001 2002 2003 2004
15-19 33 713 27 908 21 965 25 722 29 689 25 550
20-24 102 988 92 118 80 920 81 130 81 615 75 408
25-29 91 266 88 133 84 125 81 865 79 031 78 654
30-34 66 732 68 167 69 455 77 133 84 763 81 469
35-39 47 493 49 923 52 661 50 658 48 778 52 642
40-44 32 319 30 168 27 845 37 404 47 625 41 589
45-49 25 826 24 235 22 424 30 139 38 349 33 464
Total HIV infected
women (15-49) 400 337 380 652 359 395 384 051 409 850 388 776
% HIV-infected
women (15-49) 16.3 15.0 13.8 14.3 14.9 13.7
Table 4.25: Estimates of national HIV prevalence among women of reproductive age in
Malawi from 1999 to 2005 by NAC(2005)
HIV Prevalence (%)
Age Group 2000 2001 2002 2003 2004 2005
15-49 16.1 15.9 15.7 15.5 15.4 15.4
Source: Computed by author from NAC(2005)'s report.
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Figure 4.8: Comparison of this study's estimates of HIV prevalence for adult females in
Malawi with NAC (2005)'s estimates from 2000 to 2004
82
4.4 Estimates of the number of children
Estimates of the number of children born to all women of reproductive age in Malawi from
1999 to 2004 were based on ASFRs derived from the 2000 and 2004 Malawi DHSs presented
in Table 4.26. An examination of the ASFRs presented in Table 4.26 reveals that fertility
slightly declined between 2000 and 2004 in all age groups except the 30-34 age as shown in
Figure 4.9.
Table 4.26: Age-speciﬁc fertility rates (per 1 000 women) in Malawi in 2000 and 2004.
Age Group
15-19 20-24 25-29 30-34 35-39 40-44 45-49
2000 MDHS 172 305 272 219 167 94 41
2004 MDHS 162 293 254 222 163 80 35
Source: NSO and ORC Macro (2001; 2005).
As we required estimates of ASFRs for all the years starting from 1999 up to 2004 in order
to compute estimates of the number of children born to all women during this period, we
assumed a constant annual rate of change in ASFRs between 2000 and 2004 and applied linear
interpolation to the ASFRs presented in Table 4.26 above to derive estimates of ASFRs for
the missing years. Table 4.27 shows the computed estimates of ASFRs together with those
in Table 4.26. The set of ASFRs presented in Table 4.27 are the ones that were used in
computing estimates of the number of children born to all women in Malawi during the
period from 1999 to 2004.
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Figure 4.9: Comparison of age-speciﬁc fertility rates (per 1 000 women) in Malawi in 2000
and 2004.
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Table 4.27: Estimates of age-speciﬁc fertility rates (per 1 000 women) for all women in
Malawi from 1999 to 2004.
Age group 1999 2000 2001 2002 2003 2004
15-19 174 172 170 167 164 162
20-24 308 305 302 299 296 293
25-29 276 272 268 263 258 254
30-34 218 219 220 220 221 222
35-39 168 167 166 165 164 163
40-44 98 94 90 87 84 80
45-49 42 41 40 38 36 35
Estimates of ASFRs presented in Table 4.27 were applied to the estimates of the total
population of women aged 15-49 in Malawi presented in Tables 4.13 to 4.20 and yielded a
range of estimates of number of children born to all women in Malawi from 1999 to 2004
presented in Tables 4.28 to 4.31.
Estimates of the number of children born to all women followed a similar pattern as estimates
of the total number of women of reproductive age. The highest numbers of births were those
based on estimates of women using the south family of Coale-Demeny MLT system and the
lowest were those based on the UN Far East MLT system. As evident in Figure 4.10, the
estimates of the annual number of births to all women in Malawi based on the three MLTs
are almost comparable to the estimates produced by UNICEF ( 2005, 2004, 2003 and 2002).
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Table 4.28: Estimates of the number of births to all women in Malawi from 1999 to 2004 for
estimates of women based on WHO MLT system.
Age group 1999 2000 2001 2002 2003 2004
15-19 97 482 98 078 98 992 99 556 100 276 101 688
20-24 159 453 158 458 157 330 156 567 156 508 157 103
25-29 121 529 122 565 123 030 122 489 121 458 120 381
30-34 69 118 72 623 76 365 79 565 82 656 85 354
35-39 40 507 40 647 40 937 41 533 42 500 43 914
40-44 19 185 18 588 17 966 17 526 17 078 16 411
45-49 6 613 6 593 6 542 6 302 6 042 5 939
Total births 513 887 517 552 521 162 523 538 526 518 530 790
Table 4.29: Estimates of the number of births to all women in Malawi from 1999 to 2004 for
estimates of women based on UN Far East MLT system.
Age group 1999 2000 2001 2002 2003 2004
15-19 97 144 97 452 98 123 98 491 99 051 100 362
20-24 159 522 158 489 157 217 156 204 155 779 156 085
25-29 122 571 124 496 125 691 125 704 125 055 124 255
30-34 70 204 74 847 79 792 84 227 88 583 92 456
35-39 41 200 42 069 43 134 44 574 46 478 48 879
40-44 19 432 19 098 18 752 18 611 18 474 18 093
45-49 6 637 6 658 6 663 6 490 6 306 6 291
Total births 516 710 523 109 529 372 534 301 539 726 546 421
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Table 4.30: Estimates of the number of births to all women in Malawi from 1999 to 2004 for
estimates of women based on Coale-Demeny North MLT system.
Age group 1999 2000 2001 2002 2003 2004
15-19 97 366 97 812 98 541 98 889 99 358 100 517
20-24 160 198 159 750 158 968 158 358 158 266 158 779
25-29 123 163 125 662 127 400 127 907 127 704 127 276
30-34 70 550 75 569 80 920 85 777 90 575 94 885
35-39 41 411 42 490 43 767 45 426 47 562 50 216
40-44 19 554 19 329 19 082 19 030 18 975 18 662
45-49 6 697 67 72 6 828 6 694 6 543 6 562
Total births 518 939 527 384 535 506 542 081 548 983 556 897
Table 4.31: Estimates of the number of births to all women in Malawi from 1999 to 2004 for
estimates of women based on Coale-Demeny South MLT system.
Age group 1999 2000 2001 2002 2003 2004
15-19 97 421 97 940 98 762 99 218 99 815 101 136
20-24 160 258 159 870 159 153 158 609 158 589 159 208
25-29 123 276 125 876 127 700 128 275 128 124 127 752
30-34 70 673 75 818 81 298 86 280 91 200 95 626
35-39 41 513 42 693 44 069 45 828 48 070 50 832
40-44 19 610 19 438 19 239 19 235 19 224 18 950
45-49 6 716 6 811 6 886 6 770 6 634 6 671
Total births 519 467 528 446 537 107 544 215 551 656 560 175
87
0100000
200000
300000
400000
500000
600000
700000
1999 2000 2001 2002 2003 2004
Year
N
um
be
r o
f b
irt
hs
WHO
UNICEF
UN Far East
Coale-Demeny North
Coale-Demeny South
Figure 4.10: Comparison of estimates of the number of births to all women in Malawi from
1999 to 2004.
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4.5 Estimates of the number of children infected with
HIV through mother-to-child transmission
Estimates of the number of children infected with HIV through MTCT started with estimates
of the number of children born to all HIV infected women. Assuming that fertility among
15-19 years old women is 50% higher among HIV-positive than HIV-negative women and
that fertility among women 20-49 years old is 20% lower among HIV-positive women than
HIV-negative women we applied equation 3.34 outlined in the methodology section (section
3.1.5) and estimates of ASFRs for all women in Malawi from 1999 to 2004 presented in Table
4.27 to estimates of HIV-infected women presented in Tables 4.21 to 4.24 and estimates of
HIV-negative women to obtain estimates of number of births to HIV-infected women. The
estimated numbers of children born to HIV-infected women in Malawi from 1999 to 2004 are
presented in Tables 4.32 to 4.35.
Table 4.32: Estimates of the number of births to HIV-infected women in Malawi from 1999
to 2004 for estimates of women based on WHO MLT system.
Age group 1999 2000 2001 2002 2003 2004
15-19 8 547 7 038 5 510 6 328 7 163 6 117
20-24 26 289 23 090 19 939 19 761 19 672 17 940
25-29 20 712 19 413 18 013 17 019 15 972 15 546
30-34 11 871 11 908 11 931 13 031 14 164 13 422
35-39 6 477 6 608 6 765 6 290 5 853 6 138
40-44 2 562 2 235 1 922 2 455 2 966 2 389
45-49 883 793 700 883 1 050 865
Total births 77 341 71 085 64 780 65 767 66 840 62 417
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Table 4.33: Estimates of the number of births to HIV-infected women in Malawi from 1999
to 2004 for estimates of women based on UN Far East MLT system.
Age group 1999 2000 2001 2002 2003 2004
15-19 8 518 6 993 5 462 6 260 7 075 6 038
20-24 26 301 23 094 19 924 19 715 19 581 17 824
25-29 20 890 19 718 18 403 17 466 16 445 16 047
30-34 12 057 12 273 12 466 13 795 15 180 14 539
35-39 6 588 6 839 7 128 6 750 6 401 6 831
40-44 2 595 2 296 2 006 2 607 3 209 2 634
45-49 886 800 713 909 1 095 916
Total births 77 835 72 013 66 102 67 502 68 986 64 829
Table 4.34: Estimates of the number of births to HIV-infected women in Malawi from 1999
to 2004 for estimates of women based on Coale-Demeny North MLT system.
Age group 1999 2000 2001 2002 2003 2004
15-19 8 537 7 019 5 485 6 286 7 097 6 047
20-24 26 412 23 278 20 147 19 987 19 893 18 131
25-29 20 991 19 903 18 653 17 772 16 793 16 437
30-34 12 116 12 391 12 643 14 049 15 521 14 921
35-39 6 622 6 908 7 232 6 879 6 550 7 018
40-44 2 611 2 324 2 042 2 666 32 96 2 717
45-49 894 814 731 938 1 137 955
Total births 78 183 72 637 66 933 68 577 70 287 66 226
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Table 4.35: Estimates of the number of births to HIV-infected women in Malawi from 1999
to 2004 for estimates of women based on Coale-Demeny South MLT system.
Age group 1999 2000 2001 2002 2003 2004
15-19 8 542 70 28 5 497 6 307 7 130 6 084
20-24 26 422 23 296 20 170 20 019 19 934 18 180
25-29 21 010 19 937 18 697 17 823 16 848 16 499
30-34 12 138 12 432 12 702 14 131 15 628 15 038
35-39 6 638 6 941 7 282 6 940 6 620 7 104
40-44 2 618 2 337 2 058 2 694 3 339 2 759
45-49 897 819 737 948 1 152 971
Total births 78 265 72 790 67 143 68 862 70 651 66 635
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Estimates of the number of children infected with HIV through MTCT were then computed
by applying PTRs to the estimates of the total numbers of children born to HIV-infected
women in Malawi from 1999 to 2004 presented in Tables 4.32 to 4.35. Three scenarios of
PTRs in the absence of any intervention (PTR equal to 30%, PTR equal to 32% and PTR
equal to 30%) were considered together with their corresponding default values from AIM
for HIV infected pregnant women who received Nevirapine presented in Table 3.8. The ﬁnal
estimates of the number of children infected with HIV through MTCT in Malawi from 1999
to 2004 under the three scenarios are presented in Tables 4.36 to 4.39.
Table 4.36: Estimates of the number of children infected with HIV through MTCT in Malawi
from 1999 to 2004 for estimates of women based on WHO MLT system.
Base transmission rate 1999 2000 2001 2002 2003 2004
30% 23 202 21 326 19 434 19 612 19 744 18 344
32% 24 749 22 747 20 730 20 978 21 213 19 756
35% 27 069 24 880 22 673 22 960 23 240 21 656
Table 4.37: Estimates of the number of children infected with HIV through MTCT in Malawi
from 1999 to 2004 for estimates of women based on UN Far East MLT system.
Base transmission rate 1999 2000 2001 2002 2003 2004
30% 23 350 21 604 19 831 20 133 20 388 19 068
32% 24 907 23 044 21 153 21 533 21 900 20 528
35% 27 242 25 205 23 136 23 567 23 991 22 500
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Table 4.38: Estimates of the number of children infected with HIV through MTCT in Malawi
from 1999 to 2004 for estimates of women based on Coale-Demeny North MLT system.
Base transmission rate 1999 2000 2001 2002 2003 2004
30% 23 455 21 791 20 080 20 456 20 778 19 487
32% 25 019 23 244 21 419 21 877 22 316 20 975
35% 27 364 25 423 23 427 23 943 24 447 22 989
Table 4.39: Estimates of the number of children infected with HIV through MTCT in Malawi
from 1999 to 2004 for estimates of women based on Coale-Demeny South MLT system.
Base transmission rate 1999 2000 2001 2002 2003 2004
30% 23 480 21 837 20 143 20 541 20 888 19 610
32% 25 045 23 293 21 486 21 969 22 432 21 106
35% 27 393 25 476 23 500 24 043 24 574 23 132
4.6 Estimates of the number of HIV infected children
dying before the age of ﬁve years during the period
2000 to 2004
We computed estimates of the total number of children infected with HIV through MTCT
that died before attaining the age of ﬁve years during the period 2000 to 2004 in Malawi
by applying the survival curve of children infected with HIV through MTCT presented by
equation 3.37 in the methodology section (section 3.1.6) to the estimates of the numbers
of children infected with HIV through MTCT during the period 2000 to 2004 presented in
Tables 4.36 to 4.39. We assumed an even distribution in the number of children infected
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with HIV through MTCT in each year and started by computing estimates of the average
number of children infected with HIV through MTCT per month in each year from 2000 to
2004. Thereafter, applying the survival curve of children infected with HIV through MTCT
presented by equation 3.37 to the monthly estimates of the number of children infected with
HIV through MTCT we obtained estimates of the total number of children infected with
HIV through MTCT that died before their ﬁfth birthday in Malawi during the period 2000
to 2004 presented in Table 4.40. As shown in Table 4.40, for all the three scenarios of PTRs,
the south family of Coale-Demeny MLT system yielded the highest estimates of the total
number of under-ﬁve deaths among HIV-infected children in Malawi during the period 2000
to 2004.
Table 4.40: Estimates of the total number of children infected with HIV through MTCT
dying before the age of ﬁve years during the period 2000 to 2004 in Malawi.
MLT
Base WHO UN Far East Coale-Demeny North Coale-Demeny South
transmission rate
30% 45 193 46 359 47 076 47 267
32% 48 388 49 624 50 385 50 586
35% 52 963 54 321 55 152 55 386
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4.7 Estimates of under-ﬁve mortality directly attributable
to HIV/AIDS in Malawi during the period 2000 to
2004
The process of estimating the proportion of under-ﬁve mortality that is directly attributable
to HIV/AIDS in Malawi during the period 2000 to 2004 involved computing estimates of
a correction for competing causes of mortality among HIV-infected children and estimates
of U5MR due to HIV/AIDS as described in the methodology section (section 3.1.7). Using
the 2004 Malawi DHS U5MR estimate of 133 deaths per 1000 live births and the results
presented in Tables 4.29 to 4.31 and 4.40 we obtained estimates of U5MR due to HIV/AIDS
and the proportion of under-ﬁve mortality directly attributable to HIV/AIDS in Malawi
during the period 2000 to 2004 presented in Table 4.41. As Table 4.41 shows, about 11.7%
to 13.8% of under-ﬁve deaths that occured in Malawi during the period 2000 to 2004 were
due to paediatric HIV-infection contracted through MTCT. Thus, on average HIV/AIDS
directly caused about 12.7% of under-ﬁve mortality in Malawi during the period 2000 to
2004.
On the one hand, the results presented in Table 4.41 indicate that the U5MR due to
HIV/AIDS and the proportion of under-ﬁve mortality directly attributable to HIV/AIDS
depends on the PTR. A low PTR yields a low U5MR due to HIV/AIDS as well as proportion
of under-ﬁve mortality directly attributable to HIV/AIDS. On the other hand, the results
presented in Table 4.41 indicate that the type of MLT used has no eﬀect on the estimates
of U5MR due to HIV/AIDS and the proportion of under-ﬁve mortality directly attributable
to HIV/AIDS. The minor diﬀerences in the estimates of U5MR due to HIV/AIDS and the
proportion of under-ﬁve mortality directly attributable to HIV/AIDS for the same PTR
across the MLTs are due to rounding.
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Table 4.41: Estimates of U5MR due to HIV/AIDS and proportion of under-ﬁve mortality
attributable to HIV/AIDS in Malawi during the period 2000 to 2004.
MLT Base U5MR (per 1000) Proportion of
transmission due to HIV/AIDS under-ﬁve mortality
rate attributable to HIV/AIDS
WHO 30% 15.26 11.47%
32% 16.37 12.30%
35% 17.94 13.49%
UN Far 30% 15.34 11.53%
East 32% 16.44 12.36%
35% 18.03 13.56%
Coale-Demeny 30% 15.36 11.55%
North 32% 16.46 12.38%
35% 18.05 13.57%
Coale-Demeny 30% 15.36 11.55%
South 32% 16.46 12.38%
35% 18.06 13.58%
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4.8 HIV/AIDS, PMTCT programs and U5MR reduction
goals in Malawi
In this section we present results on how HIV/AIDS directly aﬀected progress towards
reaching overall under-ﬁve mortality reduction goals in Malawi. The section also presents
results on the potential contribution of PMTCT programs currently being implemented in
Malawi towards reaching the country's overall under-ﬁve mortality reduction goals.
We assessed how HIV/AIDS directly aﬀected progress towards reaching overall under-ﬁve
mortality reduction goals in Malawi by comparing estimates of U5MR due to non-HIV/AIDS
causes during the period 2000 to 2004 with an estimate of the level of U5MR needed to be
achieved by 2004 if Malawi was on track towards reaching the under-ﬁve mortality reduction
MDG. As shown in Figure 4.11, after discounting the direct eﬀects of HIV/AIDS, U5MR in
Malawi during the period 2000 to 2004 is below the level it was required to have reached
had the country been on track towards reaching the overall under-ﬁve mortality reduction
MDG depicted by the dotted horizontal line.
To assess the potential contribution PMTCT programs currently being implemented in
Malawi would make towards reaching Malawi's overall under-ﬁve mortality reduction goals
we discounted an estimated number of under-ﬁve deaths that would be averted in Malawi
during the period 2000 to 2004 if there was 100% coverage of PMTCT services from the
estimated number of under-ﬁve deaths from all causes computed using the 2004 Malawi
DHS estimate of U5MR from all causes in Malawi during the period 2000 to 2004. We then
computed an estimate of U5MR with 100% PMTCT coverage which we again compared with
the level of U5MR needed to be achieved by 2004 if Malawi was on track towards reaching the
under-ﬁve mortality reduction MDG. In our analysis we only considered a 100% coverage
of treatment with NVP as it is the only established PMTCT service available in Malawi
at the time of conducting this study (Malawi HIV and AIDS Monitoring and Evaluation
Report 2005 ). As Figure 4.11 further shows, a 100% coverage of treatment with Nevirapine
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for PMTCT could have reduced the U5MR in Malawi during the period 2000 to 2004 to
almost the level needed for being on track towards reaching the overall under-ﬁve mortality
reduction MDG only if the PTR was 30%.
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Figure 4.11: HIV/AIDS, PMTCT programs and U5MR reduction goals in Malawi assuming
a PTR of 30%.
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Chapter 5
Discussion and conclusions
This study has estimated the proportion of under-ﬁve mortality that is directly attributable
to HIV/AIDS in Malawi during the period 2000 to 2004. The steps involved in deriving the
estimates included estimating HIV prevalence among women of reproductive age using ANC
surveillance survey data and HIV prevalence results from the 2004 Malawi DHS, estimating
the number of women of reproductive age, estimating the number of HIV infected women,
estimating the total number of births in each year, estimating the total number of children
infected with HIV through MTCT, and estimating the U5MR due to HIV/AIDS. To a
large extent, the study adopted the methods and procedures recommended by UNAIDS and
WHO that are implemented in DemProj and AIDS Impact Model computer packages. To
account for uncertainties in the estimates, the study used survival ratios from four sets of
MLTs deemed to ﬁt the Malawian mortality experience and three sets of PTR assumed to
arise in SSA countries by other researchers (Stover, 2005; The UNAIDS Reference Group on
Estimates, Models and Projections, 2003; Zaba et al., 2003; Walker et al., 2002; Adetunji,
2000).
Because there were only few data points for HIV prevalence from the ANC surveillance
surveys we did not derive smoothed national estimates of HIV prevalence for women of
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reproductive age in Malawi during the period 2000 to 2004. Nevertheless, using widely used
and recommended procedures, considerable eﬀorts were made to adjust the HIV prevalence
data from the ANC surveillance surveys to derive plausible estimates of HIV prevalence in
women of reproductive age in Malawi.
The ﬁnding that estimates of national HIV prevalence for women aged 15 to 49 derived
in this study are lower than those produced by NAC (2005) suggests that estimates of
the proportion of under-ﬁve mortality that is directly attributable to HIV/AIDS in Malawi
during the period 2000 to 2004 obtained in this study may be slightly lower than those that
could be based on NAC (2005)'s national HIV prevalence estimates. However, since the
diﬀerences between this study's estimates of national HIV prevalence and those produced by
NAC (2005) are very small the conclusions drawn from the ﬁndings of this study would not
be signiﬁcantly altered if estimates of national HIV prevalence for women of reproductive
age in Malawi during the period 2000 to 2004 were derived from those produced by NAC
(2005).
The ﬁnding that the estimates of the number of women of reproductive age obtained in
this study are very close to those produced by NAC (2005) and NSO (2000) also indicates
that the estimates obtained in this study are within plausible bounds as far as the number
of women of reproductive age in Malawi are concerned. The small diﬀerence between the
estimates of the number of births in each year obtained in this study and those produced
by UNICEF (2005, 2004, 2003 and 2002) is a further indication that the estimates of the
number of births in Malawi during the period 2000 to 2004 obtained in this study are within
plausible bounds.
Although the estimates of national HIV prevalence for women of reproductive age may
be aﬀected by the small numbers of women sampled in ages 40 years and above in ANC
surveillance surveys, owing to low fertility in such women (NSO and ORC Macro, 2005) we
expect very little eﬀect on the estimates of the proportion of under-ﬁve mortality that is
directly attributable to HIV/AIDS. Furthermore, although our estimates of the proportion
of under-ﬁve mortality that is directly attributable to HIV/AIDS in Malawi during the
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period 2000 to 2004 may diﬀer from those that may be produced by other researchers and
scientists owing to varying demographic and epidemiological assumptions, we believe that the
results obtained in this study cannot greatly diverge from those that can be produced using
the WHO/UNAIDS recommended methods and procedures, particularly those implemented
in the Spectrum package (Ghys et al., 2004). This claim is supported by fact that to a
large extent this study used methods and procedures similar to those implemented in the
Spectrum package and there are small diﬀerences between the estimates of some of the
parameters needed to compute estimates of the proportion of under-ﬁve mortality that is
directly attributable to HIV/AIDS obtained in this study and those produced by other
researchers and experts using similar methods and procedures as illustrated in the results
section.
Taking the value 133 per 1 000 from 2004 Malawi DHS as an estimate of U5MR from all
causes in Malawi during the period 2000 to 2004, the main ﬁnding of this study is that
the proportion of under-ﬁve mortality that is directly attributable to HIV/AIDS in Malawi
during this period ranges from 11.53% to 13.58%. These proportions correspond to PTRs
ranging from 30% to 35% respectively. These estimates are slightly above the estimate of
8.9% produced by Walker et al. (2002) for 1999 and 11.4% produced by Zaba et al. (2003)
for 2001. Since this study used approaches that are to a great extent similar to those used
by Walker et al. (2002) in estimating the proportion of under-ﬁve mortality that is directly
attributable to HIV/AIDS, although Walker et al. (2000)'s estimates cover single years, this
study's ﬁnding suggests a possible slight increase in the direct contribution of HIV/AIDS
towards under-ﬁve mortality in Malawi during the period 2000 to 2004 compared to previous
years. Although Zaba et al. (2003) used a diﬀerent approach from the one used in this study,
this study's results can also be compared to their results since it has been found that MLT
assumptions do not aﬀect estimates of the proportion of under-ﬁve mortality attributable
to HIV/AIDS. Since Zaba et al. (2003), although again their estimates are for single years,
used a PTR of 35% which corresponds to an estimated proportion of under-ﬁve mortality
dirrectly attributable to HIV/AIDS of 13.57% from this study, the same conclusion that
the proportion of under-ﬁve mortality directly attributable to HIV/AIDS in Malawi slightly
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increased during the period 2000 to 2004 compared to the previous years can also be drawn.
From this study's assessment of how HIV/AIDS directly aﬀected progress towards reaching
overall under-ﬁve mortality reduction goals in Malawi it has been noted that HIV/AIDS
signiﬁcantly hampered the achievement of the level of U5MR needed for Malawi to be on
track towards reaching the overall under-ﬁve mortality reduction MDG. This ﬁnding indicates
that averting HIV/AIDS related deaths among children below the age of ﬁve years could help
in bringing down the overall under-ﬁve mortality in Malawi to targeted levels.
A distinct feature of this study is that apart from providing insights on how HIV/AIDS
negatively aﬀected the achievement of overall under-ﬁve mortality reduction goals in Malawi
it has also attempted to assess the potential contribution of scaling up coverage of PMTCT
services currently being provided in Malawi towards achieving the country's overall under-
ﬁve mortality reduction goals. The ﬁnding that 100% coverage of treatment with Nevirapine
to prevent MTCT of HIV infection would not have greately contributed towards reaching
overall under-ﬁve mortality reduction goals in Malawi during the period 2000 to 2004 conﬁrms
that only a comprehensive set of PMTCT services which comprise primary prevention of
HIV infection among women of reproductive age, prevention of unintended pregnancies
among HIV-infected women, prevention of MTCT transmission of HIV infection from HIV-
infected mothers to their infants and the provision of appropriate treatment, care and
support to HIV-infected mothers and their infants and families would signiﬁcantly contribute
towards reaching overall under-ﬁve mortality reduction goals (UNICEF, UNAIDS, WHO and
UNFPA, 2004). Thus, in order to make substantial contributions to the country's overall
under-ﬁve mortality reduction goals, Malawi should intensify its eﬀorts in all the four key
components of a comprehensive PMTCT program. Although Malawi has made substantial
progress in putting in place various HIV prevention programmes, as argued by the Global
HIV Prevention Working Group (2007), ﬁndings from the 2004 Malawi DHS (NSO and ORC
Macro, 2005) and the ﬁrst behavioural surveillance survey conducted in Malawi in 2004 (NAC
et al., 2004) that a number of people in Malawi still do not have accurate and comprehensive
knowledge of HIV and others still engage in high risk behaviour, means that individuals
and communities in Malawi have not yet been reached with the level of prevention coverage
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needed to have a major impact. The same argument holds for the majority of people who still
remain unaware of their HIV status. Malawi also needs to intensify coverage and availability
of HIV testing and counselling services. Furthermore, Malawi also needs to improve on
coverage and availability of contraception services especially among HIV-infected women as
a way of preventing unintended pregnancies among HIV-infected women.
According to NSO and ORC Macro (2005), the other four communicable diseases:
pneumonia, diarrhea, malaria and measles reported to be the leading causes of deaths in
children under the age of ﬁve years in developing countries by Bryce et al. (2005) and WHO
(2005a) also make a substantial contribution to Malawi's under-ﬁve mortality. Therefore,
attainment of under-ﬁve mortality reduction targets in Malawi requires both expansion of
coverage and availability of a comprehensive set of PMTCT services as well as strengthening
of eﬀorts to address these other major causes of under-ﬁve mortality.
Like other studies that have attempted to estimate the direct impact of HIV/AIDS on child
mortality this study does not capture the many indirect eﬀects of HIV/AIDS on under-ﬁve
mortality in Malawi (Walker et al., 2002; Adetunji, 2000). Therefore, due to the additional
indirect eﬀects, the overall contribution of HIV/AIDS towards under-ﬁve mortality in Malawi
during the period 2000 to 2004 is without doubt greater than obtained in this study.
In summary, there are two main conclusions drawn from the ﬁndings of this study. One
main conclusion is that HIV/AIDS has signiﬁcantly hampered achievement of Malawi's
overall under-ﬁve mortality reduction targets. The other main conclusion is that attainment
of further reductions in Malawi's under-ﬁve mortality requires both expansion of coverage
and availability of a comprehensive set of PMTCT services and strengthening of eﬀorts to
address the other major causes of under-ﬁve mortality. However, since putting in place a
comprehensive set of PMTCT services alongside strengthening eﬀorts to address the other
major causes of under-ﬁve mortality would require huge ﬁnancial resources, taking into
account Malawi's economic situation, we argue that the attainment of further substantial
reductions in Malawi's under-ﬁve mortality in the years to come depend on ﬁnancial support
from the country's international donors. Unless more ﬁnancial support become available to
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eﬀectively address HIV/AIDS and the other major causes of under-ﬁve mortality, Malawi's
under-ﬁve mortality will continue to be one of the highest in the world in the years to come.
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Appendix
R Code
This section presents R code used to compute the estimates presented in this thesis. The
code was written in a number of text ﬁles. The code in one ﬁle is linked to the code in another
ﬁle by the "source" statement. All statements beginning with # are comments explaining
what the code is doing.
code for estimating proportion of urban population code ﬁle name: U_R_popn.txt
#reading the table containing the urban and rural populations as recorded in 1987 and
1998 census reports.
urb_rural<-read.table("urban_rural_prop.txt", header=FALSE)
#combine age groups 40-44 and 45-49
urb_rural_40_49<- urb_rural[6,]+urb_rural[7,]
#creating a data table containing the urban and rural populations with age groups
40-44 and 45-49 combined
urb_rural_15_49<-rbind(urb_rural[1:5,],urb_rural_40_49)
names(urb_rural_15_49)<-c("urban_1987", "rural_1987",
"urban_1998", "rural_1998")
Age<-c("15-19", "20-24", "25-29", "30-34", "35-39", "40-49")
row.names(urb_rural_15_49)<-Age
105
#computing proportion urban in 1987 and 1998
prop_urban87<-urb_rural_15_49$urban_1987/(urb_rural_15_49$urban_1987
+urb_rural_15_49$rural_1987)
prop_urban98<-urb_rural_15_49$urban_1998/(urb_rural_15_49$urban_1998
+urb_rural_15_49$rural_1998)
prop_urban87_98<-cbind(prop_urban87,prop_urban98)
row.names(prop_urban87_98)<-Age
#computing annual proportion urban change 1987-1998
prop_urban_87_98_ac<-cbind((prop_urban87_98[,2]-prop_urban87_98[,1])/(1998-
1987))
#create a function for estimating age speciﬁc proportion urban population for any year
from 1987
prop_urban<-function(y) # y is any year <=1987
{interval<-(y-1987)
prop_urban<-prop_urban87_98[,1] +interval*prop_urban_87_98_ac
cbind(prop_urban)
}
#creating a function for estimating age speciﬁc proportion rural population for any
year from 1987
prop_rural<-function(y) # y any year <=1987
{prop_rural<-1-prop_urban(y)
cbind(prop_rural)
}
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code for adjusting HIV prevalence in non-urban sites for representativeness
code ﬁle name: ANC_NON_URBAN_80.txt
# The code in this ﬁle was used to generate the results in Table 4.6 on page 62
#reading the ﬁle containing the unadjusted HIV prevalence in aggregated non-urban
sites
NON_URBAN<-read.table("ANC_NON_URBAN.txt", header=FALSE)
Age<-c( "15-19","20-24","25-29","30-34","35-39","40-49")
year<-c(1999,2001,2003,2005)
NON_URBAN_0.8<-NON_URBAN*0.8
names(NON_URBAN_0.8)<-year
row.names(NON_URBAN_0.8)<-Age
code for estimating unadjusted national HIV prevalence
code ﬁle name: HIV_NATION.txt
#reading in the code containing the adjusted age speciﬁc HIV prevalence rates for
aggregated rural sites.
source("ANC_NON_URBAN_80.txt")
# reading the age speciﬁc HIV rates for aggregated urban sites
URBAN<-read.table("ANC_URBAN.txt", header=FALSE)
#reading the code for calculating proportion urban and rural.
source("U_R_popn.txt")
#creating a data frame containing age speciﬁc proportion urban
for the years (1999,2001,2003,2005)
prop_urban_99_05<-cbind()
for (i in seq(1999,2005,2))
{urban_prop<-prop_urban(i)
prop_urban_99_05<-cbind(prop_urban_99_05,urban_prop)
}
prop_urban_99_05<-data.frame(prop_urban_99_05)
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names(prop_urban_99_05)<-year
#creating a data frame containing age speciﬁc proportion rural for
the years 1999,2001,2003,2005
prop_rural_99_05<-1-prop_urban_99_05
prop_rural_99_05<-data.frame(prop_rural_99_05)
names(prop_rural_99_05)<-year
#calculating estimates of national HIV prevalence for the years
1999,2001,2003,2005 presented in Table 4.7 on page 63
HIV_NATION<-(prop_urban_99_05*URBAN)
+(prop_rural_99_05*NON_URBAN_0.8)
#calculating estimates of HIV prevalence for the years 2000, 2002 and 2004
HIV_NATION_2000<-0.5*(HIV_NATION[1]+HIV_NATION[2])
HIV_NATION_2002<-0.5*(HIV_NATION[2]+HIV_NATION[3])
HIV_NATION_2004<-0.5*(HIV_NATION[3]+HIV_NATION[4])
#creating a data frame containing estimates of HIV prevalence for 2000, 2002 and 2004
HIV_NATION2<-cbind(HIV_NATION_2000,HIV_NATION_2002,HIV_NATION_2004)
names(HIV_NATION2)<-c("2000","2002", "2004")
#creating a data frame containing all the estimates of HIV prevalence from 1999 to
2005 presented in Table 4.8 on page 63
HIV_NATION_ALL<-array(,dim=c(6,7))
HIV_NATION_ALL<-data.frame(HIV_NATION_ALL)
i=seq(1,7,2)
j=seq(2,6,2)
HIV_NATION_ALL[,i]<-HIV_NATION
HIV_NATION_ALL[,j]<-HIV_NATION2
names(HIV_NATION_ALL)<-1999:2005
row.names(HIV_NATION_ALL)<-Age
HIV_ANC_1999<-HIV_NATION_ALL[,1]
names(HIV_ANC_1999)<-Age
HIV_ANC_1999.table<-as.table(HIV_ANC_1999)
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code for combining HIV prevalence rates for age groups 40-44 and 45-49 from
the 2004 Malawi DHS report
code ﬁle name: HIV_DHS.txt
#The code in this ﬁle was used to generate the results presented in Table 4.9 on page
65. #creating a vector for number tested
number_tstd <-c(500,661,477,382,257,235,173)
Age<-c( "15-19","20-24","25-29","30-34","35-39","40-49")
#creating a vector containing the age speciﬁc prevalence rates for 2004 Malawi DHS
report
HIV_2004MDHS<-c(3.7,13.2,15.5,18.1,17.0,17.9,13.3)
#computing numbers HIV positive in each age group
number_postv<-(number_tstd*HIV_2004MDHS)/100
# rounding the elements in number_postv to whole numbers
number_postv.rounded<-round(number_postv)
#adding the numbers positive in age groups 40-44 and 45-49
number_postv_40_49<-number_postv.rounded[length(number_postv.rounded)] +
number_postv.rounded[length(number_postv.rounded)-1]
#adding the numbers tested in age groups 40-44 and 45-49
number_tstd_40_49<-number_tstd[length(number_tstd)]
+ number_tstd[length(number_tstd)-1]
# calculating percentage positive in 40-49 age group
percnt_postv_40_49<-(number_postv_40_49/number_tstd_40_49)*100
#creating a vector containing the age speciﬁc HIV prevalence rates for 2004 Malawi
DHS with age groups 40-44 and 45-49 combined
HIV_2004MDHS_comb<-c(HIV_2004MDHS[-c((length(HIV_2004MDHS)-1),
length(HIV_2004MDHS))],percnt_postv_40_49)
#assigning names to the elemnts in HIV_2004MDHS_comb
names(HIV_2004MDHS_comb)<-Age
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#converting HIV_2004MDHS_comb into a table.
#This makes it possible to plot the HIV prevalence rates with the age groups on the
horizontal axis
HIV_2004MDHS_comb.table<-as.table(HIV_2004MDHS_comb)
code for estimating ﬁnal national HIV prevalence
code ﬁle name: ANC_VS_DHS.txt
#The code in this ﬁle was used to produce the graph in Figure 4.5 on page 67 and
to compute estimates of ratios of ANC HIV prevalence to general population HIV
prevalence presented in Table 4.10 on page 68 and ﬁnal national estimates of HIV
prevalence adjusted using 2004 Malawi DHS results presented in Table 4.11 on page
68
#sourcing the code in HIV_NATION.txt and HIV_VS_DHS.txt
source("HIV_NATION.txt")
source("HIV_VS_DHS.txt")
#compute second HIV prevalence estimates for ANC for 2004
HIV_2004_ANC2<-1/2*(HIV_NATION_ALL[,6]+HIV_NATION_ALL[,7])
#computing the ratios of ANC to DHS estimates
ANC_2_DHS <-cbind(HIV_2004_ANC2/HIV_2004MDHS_comb.table)
#compute ﬁnal estimates of national HIV prevalence by age for the years 1999 to 2005
HIV_NATION_FINAL<-HIV_NATION_ALL/ANC_2_DHS
code for computing survival ratios corresponding to the projected life ex-
pectancy at birth values presented in Table 3.7 on page 41
code ﬁle name: survival_cal.txt
#reading the ﬁle containing survival ratios for a particular model life table
survival_table<-read.table("cdnorth.txt", header=TRUE)
#cdnorth.txt contains female survival ratios from the north family of Coale-Demeny
model life table system
#converting survival_table into a dataframe
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survival_table.frame<-data.frame(survival_table)
#calculating survival ratios corresponding to life expectancy at birth values of 43.23,
43.77, 44.33, 44.90
#start by ﬁnding the diﬀerence between survival ratios for life expectancy values of 40
and 45
life_exp40_45<-survival_table.frame$X45-survival_table.frame$X40
#divide the diﬀerence into 500 equal units
unit_life_exp40_45<-life_exp40_45/500
#Now calculate survival ratios for life expectancy at birth value of 43.23, 43.77, 44.33
and 44.90
life_exp43.23<-survival_table.frame$X40+(323*unit_life_exp40_45)
life_exp43.77<-survival_table.frame$X40+(377*unit_life_exp40_45)
life_exp44.33<-survival_table.frame$X40+(433*unit_life_exp40_45)
life_exp44.90<-survival_table.frame$X40+(490*unit_life_exp40_45)
#calculating survival ratios corresponding to life expectancy at birth values of 45.47,
46.03, 46.60 in a similar manner as above
life_exp45_50<-survival_table.frame$X50-survival_table.frame$X45
unit_life_exp45_50<-life_exp45_50/500
life_exp45.47<-survival_table.frame$X45+(47*unit_life_exp45_50)
life_exp46.03<-survival_table.frame$X45+(103*unit_life_exp45_50)
life_exp46.60<-survival_table.frame$X45+(160*unit_life_exp45_50)
#putting the 7 sets of survival ratios together
survival_ratios<-cbind(life_exp43.23,life_exp43.77,life_exp44.33,life_exp44.90,
life_exp45.47,life_exp46.03,life_exp46.60)
#extracting from survival_ratios the survival ratios of the age group(5-9, 10-14,...,45-
49)
survival_ratios5_49<-survival_ratios[8:16,]
#making survival_ratios5_49 a dataframe
survival_ratios5_49<-data.frame(survival_ratios5_49)
year<-1998:2004
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names(survival_ratios5_49)<-year
code for estimating the number of women of reproductive age in Malawi from
1999 to 2004
code ﬁle name: proj_pop.txt
#The code in this ﬁle was used to obtain estimates of women of reproductive age in
Malawi from 1999 to 2004 presented in Tables 4.15 to 4.20 on pages 71 to 73. The code
presented here is for estimates based on Coale-Demeny North model life table system
years<-1998:2004
duration<-length(years)
ages<-5:49
age_width<-length(ages)
#creating a matrix with zeros
proj_matrix<-rep(0,duration*age_width)
dim(proj_matrix)<-c(age_width,duration)
#converting the zero matrix into a data frame
proj_matrix.frame<-data.frame(proj_matrix)
names(proj_matrix.frame)<-years
row.names(proj_matrix.frame)<-ages
#reading base line population data from base_pop.csv
base_pop<-read.csv("base_pop2.csv", header=TRUE)
#base_pop.csv contains the age-smoothed female population aged 5 to 49 in Malawi
in 1998 which has been separated into single years using the Beers formulae.
#creating a function for ﬁnding ﬁve year pop groups from age 5 to age 49
pop5ages<-function(x)
{ﬁve<-c()
a=1
b=5
112
for (i in 1:9)
{total5<-sum(x[a:b])
ﬁve<-c(ﬁve,total5)
a=a+5
b=b+5
}
ﬁve}
#creating a data frame containing population in ﬁve year age groups
pop5y_grps<-function(x)
{ﬁve_y_grps<-cbind()
for (i in x)
{sum5ages<-pop5ages(i)
ﬁve_y_grps<-cbind(ﬁve_y_grps,sum5ages)
} ﬁve_y_grps
}
#sourcing ﬁle containing survival ratios
source("survival_cal.txt")
#converting ﬁve year survival ratios into single year survival ratios
#creating a function that converts ﬁve year survival ratios into single year survival
ratios by taking the ﬁfth root
ﬁve_year2single_year_survival<-function(x)
{x  (1/5)}
#converting the survival ratios in survival_cal.txt into single years
survival_ratios5_49_singles1<-ﬁve_year2single_year_survival(survival_ratios5_49)
#creating a function that replicates 5 times each 5 year survival ratio that has been
converted to single year survival ratio
ﬁve_year2single_year_survival_X5<-function(x)
{a=length(x)
b=rep(5,a)
g=rep(x,b)
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g}
survival_ratios5_49_singles2
<-ﬁve_year2single_year_survival_X5(survival_ratios5_49_singles1)
dim(survival_ratios5_49_singles2)<-dim(proj_matrix)
survival_ratios5_49_singles2.frame<-data.frame(survival_ratios5_49_singles2)
names(survival_ratios5_49_singles2.frame)<-years
row.names(survival_ratios5_49_singles2.frame)<-ages
for (i in 1:7)
{if (i==1)
{proj_matrix.frame[i:45,i]=base_pop[,2] }
else {proj_matrix.frame[i:45,i]=proj_matrix.frame[(i-1):(45-1),
(i-1)]*survival_ratios5_49_singles2[(i-1):(45-1),(i-1)]}
}
#obtaining population age 15-49 in 5 year groups
pop15_49<-pop5y_grps(proj_matrix.frame)[3:9,]
pop15_49.frame<-data.frame(pop15_49)
names(pop15_49.frame)<-years
#rounding to whole numbers
pop15_49_ﬁnal<-round(pop15_49.frame)
# creating a function for calculating total population aged 15-49
total_pop<-function(x)
{total<-c()
for (i in x)
{a=sum(i)
total<-c(total,a)}
names(total)<-names(x)
total
}
pop15_49_ﬁnal_total<-total_pop(pop15_49_ﬁnal)
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code for estimating the number of HIV-infected women
code ﬁle name: POP_INF.txt
# The code in this ﬁle was used to obtain estimates of the number of HIV-infected
women in Malawi from 1999 to 2004 presented in Tables 4.22 to 4.25 on pages 79 to
81. The code presented here is for estimates based on Coale-Demeny North model life
table system
#sourcing code in proj_pop.txt
source("proj_pop.txt")
#extracting population in 1999 to 2004
pop99_04<-pop15_49_ﬁnal[,-1]
# sourcing code for ﬁnal estimates of national HIV prevalence rates
source("ANC_VS_DHS.txt")
HIV_rates<-HIV_NATION_FINAL[1:6]
#this code gives HIV rates with the rate for 40-49 applied to age groups 40-44 and
45-49
HIV_rates2<-c()
for (i in HIV_rates)
{
rate<-i
rate2<-c(i,i[length(i)])
HIV_rates2<-cbind(HIV_rates2,rate2)
} HIV_rates2.frame<-data.frame(HIV_rates2)
names(HIV_rates2.frame)<-c("1999","2000","2001","2002","2003","2004")
row.names(HIV_rates2.frame)<-c("15-19","20-24","25-29","30-34","35-39","40-44","45-
49")
#computing number of women aged 15-49 infected with HIV
inf_w<-round((pop99_04*HIV_rates2.frame)/100)
names(inf_w)<-c("infw_1999","infw_2000","infw_2001",
"infw_2002","infw_2003","infw_2004")
row.names(inf_w)<-row.names(HIV_rates2.frame)
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#computing total number of HIV infected women
inf_w_total<-total_pop(inf_w)
#computing HIV prevalence in 15-49 age group in 1999 to 2004
HIV_prev_adult<-inf_w_total/pop15_49_ﬁnal_total[-1]*100
#comparing estimates of HIV prev for female adults with spectrum estimates by NAC
NAC_female_HIV_15_49<-c(409171,414190,419204,424074,431723,443463)
NAC_female_15_49_total<-c(2542202,2606648,2671371,2737315,2807144,2881101)
NAC_prev_adult<-(NAC_female_HIV_15_49/NAC_female_15_49_total)*100
names(NAC_prev_adult)<-names(HIV_NATION_FINAL)[-1]
NAC_VS_CHO<-NAC_prev_adult[-6]-HIV_prev_adult[-1]
code for estimating age-speciﬁc fertility rates in Malawi from 1999 to 2004
code ﬁle name: ASFR.txt
# The code in this ﬁle was used to produce the graph in Figure 4.9 on page 84 and to
obtain estimates of age-speciﬁc fertility rates in Malawi from 1999 to 2004 presented
in Table 4.27 on page 85.
Ages<-c("15-19","20-24","25-29","30-34","35-39","40-44","45-49")
ASFR_2000<-c(172,305,272,219,167,94,41)
names(ASFR_2000)<-Ages
ASFR_2004<-c(162,293,254,222,163,80,35)
names(ASFR_2004)<-Ages
ASFR_2000.table<-as.table(ASFR_2000)
ASFR_2004.table<-as.table(ASFR_2004)
#calculating estimates of ASFR annual rate of change between 2000 and 2004.
ASFR_2000_2004<-ASFR_2000.table-ASFR_2004.table
ASFR_2000_2004_year_change<-ASFR_2000_2004/4
ASFR00_04<-c(ASFR_2000.table)
for (i in 1:4)
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{ASFR<-round(ASFR_2000.table-(i*ASFR_2000_2004_year_change))
ASFR00_04<-cbind(ASFR00_04,ASFR)
}
#estimating ASFR for 1999
ASFR99<-round(ASFR_2000.table+ASFR_2000_2004_year_change)
# producing estimates of ASFR from 1999 to 2004
ASFR99_04<-cbind(ASFR99,ASFR00_04)
ASFR99_04.frame<-data.frame(ASFR99_04)
names(ASFR99_04.frame)<-c("ASFR1999", "ASFR_2000","ASFR_2001",
"ASFR_2002","ASFR_2003","ASFR_2004")
#row.names(HIV_rates2.frame)<-c("15-19","20-24","25-29","30-34","35-39","40-44","45-
49")
code for estimating number of births
code ﬁle name: births.txt
# The code in this ﬁle was used to obtain estimates of the number of births to both
all women of reproductive age and HIV-infected women.
#sourcing code in POP_INF.txt
source("POP_INF.txt")
#sourcing code in ASFR.txt
source("ASFR.txt")
#computing number of births to all women of reproductive age from 1999 to 2004
births99_04<-round((pop99_04/1000)*ASFR99_04.frame)
#computing total number of births to all women
births99_04_total<-total_pop(births99_04)
#computing births to HIV positive women
birth_inf15_19<-(1.5*(pop99_04[1,])*ASFR99_04.frame[1,]*(inf_w[1,]))/(1.5*inf_w[1,]
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+ (pop99_04[1,]-inf_w[1,]))
birth_inf20_49<-((pop99_04[-1,])*ASFR99_04.frame[-1,]*(inf_w[-1,]))/(inf_w[-1,] +
1.25*(pop99_04[-1,]-inf_w[-1,]))
inf_w_births<-round(rbind(birth_inf15_19,birth_inf20_49)/1000)
inf_w_births_total<-total_pop(inf_w_births)
# Estimating the number of children infected with HIV through MTCT
# creating a vector for number of women receiving NVP from 1999 to 2004
nvp<-c(0,0,0,840,2198,2719)
inf_w_births_nvp<-nvp
names(inf_w_births_nvp)<-names(inf_w_births)
#computing number of children whose mothers did not receive NVP
inf_w_births_nvp_free<-inf_w_births_total-inf_w_births_nvp
#computing number of children infected via MTCT assuming PTR of 30% for no NVP
and 16% for NVP
inf_births30<-round((inf_w_births_nvp_free*0.3)+(inf_w_births_nvp*0.16))
#computing number of children infected via MTCT assuming PTR of 32% for no NVP
and 24% for NVP
inf_births32<-round((inf_w_births_nvp_free*0.32)+(inf_w_births_nvp*0.24))
#computing number of children infected via MTCT assuming PTR of 35% for no NVP
and 28% for NVP
inf_births35<-round((inf_w_births_nvp_free*0.35)+(inf_w_births_nvp*0.28))
#Estimates with 100% nvp coverage
inf_births30_nvp<-round(inf_w_births_total*0.16)
inf_births32_nvp<-round(inf_w_births_total*0.24)
inf_births35_nvp<-round(inf_w_births_total*0.28)
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code for survival curve of HIV-infected children
code ﬁle name: child_HIV_survival.txt
# The code in this ﬁle was used to generate the survival curve of HIV-infected children
and produce the graph in Figure 3.1 on page 48.
#creating a function for calculating the proportion of children dying due to HIV after
t years since birth
children_dying<-function(t)
{p=0.6
a_1=0.9
a_2=10
b_1=0.9
b_2=0.1
d_t<-(p*(1-exp(-(b_1*t)  a_1))+(1-p)*(1-exp(-(b_2*t)  a_2)))
d_t}
#creating a function for calculating the proportion of children not dying due to HIV
after t years since birth
children_surving<-function(t)
{1-children_dying(t)
}
t=seq(0,13,0.1)
survivors<-children_surving(t)
survival_table=cbind(t,survivors)
#plotting the survival distribution
plot(t,survivors*100, type="l", col=4, xlab="Age of child", lwd=1, ylab="Percentage
Surviving")
axis(1, xaxp=c(0, 13, 13)) #speciﬁes the interval in the x axis
axis(2, yaxp=c(0,100,10)) #speciﬁes the interval in the y axis
grid(lwd=1)
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code for estimating the number of HIV-infected children dying before their ﬁfth
birthday during the period 2000 to 2004
code ﬁle name: cummulative_dying.txt
# The code in this ﬁle was used to compute estimates of the number of HIV-infected
children dying before their ﬁfth birthday during the period 2000 to 2004 presented in
Table 4.40 on page 94. The code presented here is for PTR=30%
#calculating total number of children under ﬁve years dying due to HIV
#sourcing code for births
source("births.txt")
#sourcing code for survival curve of HIV-infected children
source("child_HIV_survival.txt")
#computing average number of children infected with HIV thru MTCT per month in
each year from 2000 to 2004
average_inf_births<-round(inf_births30[-1]/12)
#for each year, replicating the average number of infected children 12 times so that
the total should be equal to the total for that year
inf_births_monthly<-rep(average_inf_births, rep(12,length(average_inf_births)))
time<-59:0
prop_dying<-children_dying(time/12)
HIV_deaths<-round(average_inf_births*prop_dying)
total_HIV_deaths_00_04<-sum(HIV_deaths)
code for estimating the proportion of under-ﬁve mortality directly attributable
to HIV/AIDS in Malawi during the period 2000 to 2004
code ﬁle name: cummulative_dying.txt
# This code is the second part of the code in cummulative_dying.txt and was used to
produce estimates of U5MR due to HIV/AIDS and proportion of under-ﬁve mortality
attributable to HIV/AIDS in Malawi during the period 2000 to 2004 presented in Table
120
4.41 on page 96. The code presented here is for PTR=30%
total_HIV_inf_births<-sum(inf_births30[-1])
total_births_00_04<-sum(births99_04_total[-1])
total_u5m_all_cause_00_04<-round(total_births_00_04*133/1000)
total_u5m_HIV_neg_00_04<-total_u5m_all_cause_00_04-total_HIV_deaths_00_04
u5mr_non_HIV<-total_u5m_HIV_neg_00_04/total_births_00_04*1000
#estimate of mortality in HIV-infected children adjusted for competing causes
total_HIV_deaths_adj<-
total_HIV_deaths_00_04-round(u5mr_non_HIV*total_HIV_deaths_00_04/1000)
HIV_u5mr_adj<-(total_HIV_deaths_adj/total_births_00_04)*1000
#estimate of HIV attributable under-ﬁve mortality
HIV_mort_PAF<-(HIV_u5mr_adj/133)*100
#estimates wth 100% nvp covearage
average_inf_births_nvp<-round(inf_births30_nvp[-1]/12)
#for each year, replicating the average number of infected children 12 times so that
the total should be equal to the total for that year
inf_births_nvp_monthly<-rep(average_inf_births_nvp,
rep(12,length(average_inf_births_nvp)))
HIV_deaths_nvp<-round(average_inf_births_nvp*prop_dying)
total_HIV_deaths_nvp_00_04<-sum(HIV_deaths_nvp)
nonvp_nvp<-total_HIV_deaths_00_04-total_HIV_deaths_nvp_00_04
total_u5m_all_cause_nvp_00_04<-total_u5m_all_cause_00_04-nonvp_nvp
u5mr_all_cause_nvp_00_04<-
(total_u5m_all_cause_nvp_00_04/total_births_00_04)*1000
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